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Abstract 
Structural and functional analysis of the human cmesin subunits Rad21 and SA2 
Yunyun Jiang 
The cohesin complex is responsible for the fidelity of chromosomal segregation 
during mitosis. It consists of four core subunits namely Rad21/Mcdl/Sccl, Smcl, Smc3 
and one of the yeast Scc3 orthologs SAl or SA2. Sister chromatid cohesion is formed by 
the cohesin complex during DNA replication and maintained until the onset of anaphase. 
Among the many proposed models of how cohesin holds sister chromatids together, the 
'core' cohesin subunits Smcl, Smc3 and Rad21/Mcdl/Sccl are almost universally 
displayed as forming a contiguous ring. However, other than its supportive role in the 
cohesin ring, little is known about the fourth core protein SAIISA2- despite its physical 
association to the cohesin ring. To gain deeper insight into how physically and 
physiologically SA2 interacts with the cohesin complex, we performed structural 
characterization of SA2 and Rad21 and mapped the interaction region of the two proteins 
in vitro and ex vivo. We found SA2 interacts with Rad21 at multiple domains while 
Rad21 only interacts with SA2 through a 10 amino acid a.-helical motif from 383-392aa. 
Deletion of these 10 amino acids or mutation of three conserved amino acids (L385, 
F389, and T390) in this a.-helical motif prevents Rad21 from physically interacting with 
SA2/SA I and causes premature sister chromatid separation in mitotic cells that often 
leads to aneuploidy. Our studies provide a model for how SA2 structurally strengthens 
the cohesin ring through its interaction with Rad21. Results from our structural 
characterization of these two proteins also provided directions for further investigation of 
the structural basis of protein-protein interaction in the cohesin complex. 
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Chapter I. Introduction 
1.1 Cancer and aneuploidy 
Aneuploidy is a type of chromosome abnormality, in which the number of total 
chromosomes is not an exact multiple of a haploid set. In human, aneuploidy is a 
characteristic feature of most if not all cancers (reviewed by Panigrahi et a/., 2009). 
Previous data has shown that aneuploidy is frequently observed in solid tumors including 
breast cancer and non-small cell lung cancer tissues (Choma et a/., 2001). Aneuploid 
tumors have been found to be correlated with the poorer prognosis of breast, gastric, 
pancreatic cancer comparing to the diploid tumors (Nakopoulou eta/., 2007; Ikeguchi et 
al., 1995; Sciallero et a/., 1993). Therefore, a better understanding of the cause of 
aneuploidy leads to better understanding of tumorigenesis and the development of 
therapeutic methods. 
Aneuploidy can be a result of inaccurate chromosomal segregation. Chromosomal 
missegregation can be caused by many factors, one of which is the defects in sister 
chromatid cohesion and separation. The cohesion between sisters chromatids forms 
during the replication of chromosomes in S phase. In metaphase, the sister chromatids are 
pulled by microtubules through the kinetochores towards opposing spindle poles 
(Nasmyth, 2001). If there is no resistance against the pulling force, the sister chromatids 
will likely be pulled towards the spindle poles in an uncontrolled manner. The cohesion 
between sister chromatids provides the resistance against the pulling. When the resistance 
and the pulling force reach equilibrium, sister chromatids are able to align in the same 
plane. Then, the cohesion between sister chromatids is destroyed and sister chromatids 
----------------------
are separated from each other, completing the transition from metaphase to anaphase. 
The failure in the formation and maintenance of the cohesion between sister chromatids 
results in premature sister chromatid segregation, which is thought to be a major pathway 
to aneuploidy. On the other hand, inadequate separation of the sister chromatids can 
result in the lagging of chromosomal segregation to the opposite poles, thus culminating 
in aneuploidy. 
1.2 Introduction to the cohesin complex 
1.2.1 Overview of the cohesin complex and its subunits 
The chromosomal cohesion (i.e., holding the sister chromatids together) is 
provided by a multi-subunit complex called cohesin. The mitotic cohesin complex is 
conserved from yeast to human (Guacci et al., 1997; Michaelis et al., 1997; Darwiche et 
al., 1999; Vass et al., 2003). It consists of four core subunits, which are known as Rad21 
(Mcdl/Sccl in yeast), Structure Maintenance of Chromosomes (SMC) proteins, Smcl 
and Smc3, and either one of the yeast Scc3 orthologs, SAl or SA2 (also known as 
stromal antigens STAG I and STAG2) (Uhlmann, 2001; Hagstrom et al., 2003; Losada et 
al., 2000). 
In addition to the 'core' subunits, there are other subunits known to associate with 
the cohesin complex, such as PdsS (PdsSa and PdsSb in vertebrates), Wapi (Rad61 in 
yeast) (Panizza et al., 2000; Losada et al., 2005; Kueng eta/., 2006; Nishiyama eta/., 
2010) and Sororin (Schmitz et al., 2007). 
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1.2.2 Introduction to the cohesin subunits 
Since the identification of the cohesin core subunit more than a decade ago 
(Guacci eta/., 1997), intensive research has been conducted to functionally characterize 
the cohesin subunits. Table I lists the main cohesin subunits in yeast and human and their 
general information, including their size and sequence homology between organisms. 
Cohesin subunits Number of aa/MW Sequence similarity 
between the yeast and 
Yeast Human Yeast Human human protein 
Sccl/ 
Mcdl Rad21 566/63.2kD* 631/71.7kD* -30% 
Smcl Smcl 1225/14lkD 1233/143kD -54% 
Smc3 Smc3 1230/14lkD 1217/142kD -56% 
Scc3 SAI/2 1150/133kD SAl: 1258/141 kD Yeast Scc3 and SAl: 38% SA2: 1231/14lkD Yeast Scc3 and SA2: 31% 
Pds5 Pds5a, 1150/133kD Pds5a: 1337/15lkD Yeast Pds5 and Human Pds5b Pds5b: 1447/165kD Pds5a/Pds5b: 41% 
Rad61 Wapi 647/74.7kD 1190/133kD* -20% 
Table 1. A list of the information of human cohesin complex subunits from the NCBI 
database. *:Both human and yeast Rad21 show an apparent MW of -120kD in an SDS-PAGE 
gel and the human Wapi shows an apparent MW of -170kD in an SDS-PAGE gel. 
SMC proteins are large coiled coil proteins which form the 'backbone' of the 
cohesin complex. They are consisted of five domains, in which three of them are globular 
and the other two are 50nm-long coiled coil regions (Figure l.la; Melby et al., 1998). 
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The two long coiled coil regions are formed in an anti-parallel manner, connecting the 
three globular domains, two of which are encoded by amino acids from theN- and the C-
termini of the protein respectively, and the third one is encoded by amino acids from the 
center of the protein. Rotary metal shadowed electron-micrographs have revealed that in 
the cohesin complex, the center globular region of the SMC proteins each forms a hinge 
domain, via which, Smc1 and Smc3 form a V shaped heterodimer (Anderson et al., 2002; 
Haering et al., 2002). Co-purification of different domains of the yeast cohesin SMC 
proteins from insect cells also confirmed that only the hinge domains, but not other 
domains, of the SMC proteins could co-purify with each other (Haering et al., 2002). 
This finding is consistent with the conclusion from the EM observation. The crystal 
structure of the mouse hinge domain has recently been solved (Figure 1.1 b; Kurze et al., 
2010), suggesting that the hinge domain contains a positively charged channel, which 
potentially functions as an entry gate for positively charged DNA molecules. On the other 
end of the coiled coil region, the N- and C-terminus of the SMC protein form an ATP 
binding cassette (ABC) like nucleotide-binding domain (NBD) (Haering et al., 2002; 
Hirano et al., 2002). 
Previous studies have found that the 115 amino acids (aa) from theN-terminus of 
the yeast Rad21 could co-purify with the Smc3 NBD and the C-terminal 180aa of Rad21 
could co-purify with the Smcl NBD (Haering et al., 2002; Gruber et al., 2003), 
suggesting Rad21 binds to Smc3 and Smcl via its N-and C-terminus, respectively. When 
Rad21 is cleaved by Separase, the N- and the C-terminus of Rad21 still remain associated 
with each other, suggesting that Rad21, Smc1 and Smc3 form a ring (Gruber et al., 
2003). 
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(a) (b) 
Smc3 
(c) (d) 
Smc3 
Figure 1.1 Structures of the cobesin subunits. (a) Illustration of the cohesion SMC protein 
structures (adapted from Haering et al., 2002). (b) Crystal structure of the mouse Smc3-Smcl 
hinge domain (from Kurze et al., 2010), the residues marked in yellow form a positively charged 
channel. (c) Crystal structure of the yeast Sccl C-terminus in complex with the yeast Smc 1 
ATPase head domain (from Haering et al., 2004). (d) In yeast, Scc3 associates with the cohesin 
complex through binding to Sccl (adapted from Haering et al., 2002). 
5 
The structure of the yeast complex formed by the C-terminus of Rad21 and the 
Smc1 NBO has been solved (Figure l.lc; Haering eta/., 2004). The C-terminus ofRad21 
forms a winged-helix domain (WHO) which binds to two C-terminal f3-strands of the 
Smc 1 NBO through hydrophobic interactions. The complex contains an A TP binding 
pocket. The ATP hydrolysis catalyzed by the ATPase domain (i.e., NBO) is required for 
cohesin's association with chromosomes (Arumugam eta/., 2003). The WHO increased 
the ATPase activity of Smc11Smc3 by increasing the binding of ATP to the Smc1 head 
(Haering et al., 2004; Arumugam eta/., 2006). TheN-terminus of Rad21 and the Smc3 
head domain also forms an ATPase domain (Haering et al., 2003). Interestingly, mutation 
of amino acids either within the Rad21 C-terminal WHO or the Smc1 C-terminal f3-
strands eliminates all association between Sec 1 and Smc 113 in vivo (Haering et a/., 2004 ), 
which suggests that the WHO-Smc 1 interaction may initiate the association of Sec 1 to 
the Smc1/Smc3 heterodimer, after which the binding between the Smc1 NBO and theN-
terminus of Sec 1 takes place. 
It has been reported that the yeast Scc3 does not directly bind to the Smc1/Smc3 
heterodimer (Figure l.ld; Haering et a/., 2002). It associates with the cohesin ring 
through direct binding to the C-terminal Separase cleavage product ofRad21 (269-566aa) 
(Haering et a/., 2002; Gruber et a/., 2003). However, it is unknown how the human 
SA 112 associates with the cohesin complex. The two human Scc3 orthologs, SA 1 and 
SA2, do not co-exist in the same cohesin complex (Losada eta/., 2000). The relative 
abundance of the two orthologs varies among organisms. For example, Xenopus egg 
extracts contains ten times more cohesinsAt than cohesin8A2, while HeLa cell extracts 
contains three times more cohesin8A2 than cohesinSAt (Losada et al., 2000). The 
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biological significance of the variation in the relative abundance of the two Scc3 
orthologs among different organisms is unknown. 
In humans, the SAl and SA2 share 70% overall sequence identities (Figure 1.2). 
For SA2, most of the amino acid variations with SAl are located in theN-terminal l-
68aa and the C-terminal 1075-1162aa regions. SAl and SA2 have been reported to play 
different roles in chromosomal cohesion. SA 1 has been shown to preferentially involve in 
telomere cohesion, which also affects arm cohesion (Canudas eta/., 2009). SA2 might 
play a role in arm cohesion and centrimeric cohesion (Hauf eta/., 2005). It is not known 
how the cohesinsAt and cohesinsA2 can function differently in the sister chromatid 
cohesion. It is possible that they are located at different loci on the chromosome to 
perform their different biological function. 
Pds5 (precocious dissociation of sister chromatids) is composed of HEAT repeats 
and there are two Pds5 orthologs Pds5A and Pds5B in vertebrates (Losada eta/., 2005). 
Compared to the cohesin 'core' subunits, it binds more loosely to the cohesin complex 
and it maintains sister chromatid cohesion during G2 phase (Hartman et a/., 2000; 
Panizza eta/., 2001). It is found that Pds5 localized to the chromatin in a cell-cycle 
dependent manner similar to Rad21 (Hartman eta/., 2000). In yeast, Pds5 associates with 
the cohesin complex through binding to Scc3 (Rowland et a/., 2009). However, this 
binding only occurs in the existence of the yeast Wapi homolog, Rad61 and the three 
proteins are able to form a Scc3-Rad61-Pds5 complex in vitro (Rowland eta/., 2009). In 
humans, it was found that, Pds5B has the intrinsic property of binding with Rad21. 
However, the binding is stronger in the presence of SAl (Shintomi eta/., 2009). It is not 
known ifPds5A binds to Rad21 and SAl in the same manner. 
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Figure 1.2 Sequence alignment of the human SAl and SAl. The sequence alignment is 
prepared using BioEdit (Hall, 1999). 
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Wapl forms stable complex with Pds5A in HeLa cells (Kueng eta/., 2006). The 
depletion of Wapl increases the number of cohesin complexes associated with chromatin 
and prolonged the cohesin association during mitosis. It is thus likely that Wapl plays a 
role in the cohesin dissociation possibly by having an indirect effect on the opening of the 
cohesin ring either through the A TPase domain or the Smc 1/Smc3 hinge domain. 
Sororin, as a Wapl antagonist, has only been identified in vertebrates (Rankin et 
al., 2005; Nishiyama et al., 2010). Sororin maintains the cohesion of sister chromatids by 
inhibiting the dissociation of cohesin from chromosomes caused by Wapl (Nishiyama et 
al., 2010). 
1.2.3 The models of the cohesin complex 
There are several models proposed to explain how the cohesin complex holds the 
sister chromatids together (Anderson et al., 2002; Haering, et al., 2003; Huang eta/., 
2006; Milutinovich eta/., 2003; Zhang eta/., 2008). Among them, the most dominant 
ones are the one-ring embrace model (Gruber et al., 2003; Haering et al., 2003) and the 
two-ring handcuff model (Zhang et al., 2008). 
The one-ring embrace model (Figure 1.3 a) was proposed in yeast. It has already 
been shown that Smc1, Smc3 and Sccl form a tripartite ring, while Scc3 associates with 
the ring through binding to Sccl (Haering et al., 2002; Gruber et al., 2003). In one-ring 
model, both of the sister chromatids are entrapped in the same cohesin ring. At the onset 
of anaphase, Separase cleaves Rad21, which opens the ring and releases sister chromatids 
from cohesion. This model explains how the 38om cohesin ring holds yeast sister 
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chromatids each with a 9nm diameter together. However, when it comes to higher 
eukaryotes, the diameter of each sister chromatid is 30nm, and therefore the ring is not 
big enough to entrap both sister chromatids. The region of sister chromatids near the 
cohesin binding sites may undergo some topological change to allow the loading of the 
cohesin complex. However, it is now known how this exactly takes place. 
To solve the contradiction raised from the size, a handcuff model was proposed 
(Zhang eta/., 2008). In the handcuff model, there are two sets ofSmcl, Smc3 and Rad21, 
each forming a cohesin ring and each ring entraps one sister chromatid. This model was 
proposed based on the finding that differently tagged Smc I, Smc3 and Rad21 can pull 
down each other in mammalian cells. However, neither SA I nor SA2 was able to pull 
down itself, suggesting that there is only one molecule of either SAl or SA2 in each 
cohesin complex. A Fluorescent protein fragment complementary assay showed that two 
yellow fluorescent proteins (YFP) fused Rad21 molecules can only emit fluorescence 
when the YFP tags are located at different termini of the Rad21 molecules, indicating that 
the two Rad21 molecules interact with each other in an anti-parallel manner. The Rad21-
Rad21 interaction is significantly reduced when SAIISA2 is knocked down from the 
cells. Therefore, the interaction is dependent on SA l/SA2. The handcuff model suggests 
that the two rings are held together by the anti-parallel interaction of the two Rad21 
subunits and SA l/SA2 fortifies the handcuff (Figure 1.3b ). The handcuff model explains 
the contradiction from the one-ring embrace model, in which one ring is not big enough 
to hold sister chromatids. However, it is unclear if the dimerization of Rad21 is directly 
caused by the SA I /SA2 subunit or through other cohesin associated components. 
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(a) 
Smc3 
(b) 
Smc1 Smc3 
Smc3 Smc1 
Figure 1.3 The models of the cohesin complex. (a) One-ring embrace model from yeast 
(Adapted from Haering et al. , 2002). (b) Two-ring handcuff model from humans (from Zhang et 
al. , 2008). 
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1.2.4 The establishment of the cohesion 
The cohesin complex associates with chromosomes before DNA replication (Hauf 
et al., 2005). The cohesin complexes are loaded onto chromosomes via the opening of the 
Smcl/Smc3 hinge by the Scc2-Scc4 loading complex (Ciosk et al., 2000; Gruber eta/., 
2006). Scc2 contains multiple HEAT repeats and Scc4 consists of TPR repeats. The 
Scc2-Scc4 complex is highly conserved from yeast to human. It is unclear how exactly 
the Scc2-Scc4 complex promotes the cohesin loading. It is likely that the complex helps 
to open the cohesin ring by facilitating the changes in topology of the ring and/or 
bringing the cohesin complex closer to chromosomes for them to associate. The Scc2-
Scc4 complex may also be able to modifY the chromatid fiber to ease its entry into the 
cohesin ring. Recent studies have also shown Escol (Ecol in yeast), which is an acetyl 
transferase, facilitates the establishment of cohesion by modifYing Smc3 at two 
consecutive lysine sites in its ATPase domain (Terret eta/., 2009; Peters et al., 2009). 
The Smc3 acetylation seems to increase inS phase, which is suggested to depend on the 
Scc2-Scc4 loading complex (Una) et al., 2008). The acetylation starts decreasing at 
anaphase which is suggested to be triggered by the dissociation of the cohesin complex 
from sister chromatids (Nasmyth et al., 2009). 
It was mentioned in section 1.2.2 that cohesin8A 1 and cohesinsA2 might localize 
differently on the chromatin which resulted in their different functions. It is unknown 
how cohesin8A 1 and cohesin8A2 in vertebrates may be loaded to different loci of the 
chromatin as to function differently. SAl and SA2, the Scc3 subunits, share high 
sequence identity in most part but vary in both N- and C- termini. The difference in their 
sequences can lead to their binding to different proteins. The different proteins they bind 
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to might cause them to locate on different loci on the chromosomes. For example, SA 1 is 
found to regulate telomere cohesion. The telomeric protein TIN2 may assist in the 
localization of cohesinsA 1 for the cohesion regulation to take place. Another possibility is 
that the different sequences lead to different structures for both proteins, especially at 
both N- and C-termini, thus affects the overall cohesin complex confirmation. The 
difference in the conformation of different cohesin complexes can lead to their selective 
binding to different loci of the chromatin. It is not known whether the Scc2/Scc4 complex 
is involved in this process. 
(a) Hinge Cohesive complex 
(b) 
Figure 1.4 Models for the establishment of cohesion between sister chromatids. (a) One-ring 
model, the hinge domain transiently opens as the replication forks passes through and recloses 
afterwards (adapted from Kurze et al. , 2010). (b) Two-ring model, cohesin rings slide onto one of 
the chromatids when they pass the replication fork before they are connected by SAl /2 (adapted 
from Zhang et al., 2009). 
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The loading of the cohesin complex occurs before the DNA replication. 
Therefore, question on how the replication fork passes the cohesin complex needs to be 
answered. An explanation was given for the one-ring embrace model based upon the 
structural information of the Smcl/Smc3 hinge domain, which contains a positively 
charged channel with DNA-binding potential (Kurze et a/., 2010). When DNA is 
replicated, the replisome passes the cohesin ring, the Smc 1/Smc3 hinge transiently opens 
and the sister chromatids are co-entrapped by the cohesin ring (Figure 1.4a; Gruber et al., 
2006; Kurze eta/., 2010). With the opening of the hinge domain, the coiled coil arms 
bend and the hinge domain transiently associates with the Smc3 NBD, which triggers the 
acetylation of Smc3. Once Smc3 is acetylated, the hinge domain reassociates with each 
other, leading to the re-closing of the cohesin ring. It is likely that the acetylation cause 
the conformation change of Smc3 NBD thus to abrogate the interaction with the hinge 
domain or to 'straighten' the bent coiled coil arm, leading to there-closing of the cohesin 
ring. Furthermore, because the two consecutive acetylated lysine sites are adjacent to the 
A TP binding pocket, the conformational change may also involve an A TP hydrolysis 
cycle. However, it is unclear if the coiled-coil arms are flexible enough for the Smc3 
hinge domain to 'fold' into the NBD, which requires the 'upper' halfofthe arm (i.e., the 
arm part flanking the hinge domain) to fold for almost 180 degrees. Even the Smc3 hinge 
domain does interact with its NBD, it is unknown whether and how the interaction will 
trigger the acetylation of the NBD. 
In the handcuff model, each ring passes the replication fork by the opening of the 
Smc3 head and the Rad21 N-terminus and "slide" onto one of the sister chromatids 
(Figure 1.4b; Yeh et al, 2008). The cohesin rings on the sister chromatids are then paired 
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and connected by SA 112 with the possible assistance of other cohesin associated 
components (Zhang et al., 2008; Zhang and Pati, 2009). Compared to the one-ring model, 
handcuff model better explains how the cohesin complex passes the replication fork. 
However, it is unclear how cohesin rings are paired with each other. For the two cohesin 
rings to pair, first they need to locate at the same locus on each sister chromatid to have a 
close proximity for interaction. The cohesin complexes are reported to locate at certain 
loci on sister chromatids (Y eh et al., 2007), which supports the above hypothesis. 
Second, the two cohesin complexes are required to associate with each other. It has been 
reported that two Rad21 molecules interact with each other in an anti-parallel manner 
with the existence of SAl or SA2 (Zhang et al., 2008). Therefore, it is likely that SA112 
is the connector for the two cohesin ring. However, it is unclear how the 'connection' 
takes place. It is not known whether it is a direct interaction or through recruiting other 
cohesin associated protein. Furthermore, each cohesin carries one molecule of SAl or 
SA2, while the handcuff pair only carries one instead of two molecules of SA 112. 
Therefore, one of the SA11SA2 molecules needs to be dissociated from the cohesin 
complex in the pairing process. However, it is unknown how this dissociation takes place. 
1.2.5 The dissociation of the oohesin complex 
The dissociation of the cohesin complex from the chromatids differs in yeast and 
higher eukaryotes. In yeast, the dissociation of all the cohesin complexes takes place at 
the metaphase to anaphase transition through the anaphase-promoting complex or 
cyclosome (APC/C)-Separase pathway (Figure 1.5), in which Rad21 is cleaved by an 
activated endopeptidase (Uhlmann et al., 1999; Uhlmann et al., 2000). Separase is a large 
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protein (the human Separase is over 200kD). Separase protein contains a supercoiled 26 
Armadillo (ARM) repeats in the N-terminus, followed by a unstructured region and two 
caspase folds, of which only the second one seems to be active through detailed 
bioinformatic analysis (viadiu et al., 2005). Before the transition from metaphase to 
anaphase, Separase is bound to its inhibitor, securin (Zou et a/., 1999) and remains 
inactive. The binding is likely extended from the ARM repeats to the caspase fold 
(Viadiu eta/., 2005). At the onset of anaphase, an ubiquitin protein ligase, APC/C, is 
phosphorylated by a kinase called Cdkl (Kraft eta/., 2003). APC/C is then able to bind 
to one of its activators, Cdc20, which recruits one of its substrates, securin (reviewed by 
Peters, 2002). Securin is then degraded and dissociates from Separase. Upon the 
dissociation of securin, Separase is activated by self-cleavage. Rad21 is then cleaved by 
the activated Separase at R180 and R268 (Uhlmann et al., 1999), which leads to the open of 
the cohesin ring and the dissociation of all the cohesin complexes. 
In higher eukaryotes, the dissociation of cohesin complexes takes place in two 
steps (Figure 1.5; Waizenegger et a/., 2000). In prophase, the bulk of the cohesin 
complexes along the sister chromatid arms are removed through the phosphorylation of 
SA2 by a polo-like kinase (Plkl) (Sumara eta/., 2000; Sumara eta/., 2002; Gimenez-
Abian eta/., 2004). This is called the prophase pathway, which is independent of the 
APC/C mediated Separase activation. An orthologs of the D. melanogaster wings apart-
like protein (Wapi) also plays an important role in the removal of arm cohesion possibly 
by unlocking cohesin from stably binding to chromatin (Kueng eta/., 2006). The residual 
cohesin complex on the arms along with the centromere cohesin complexes are protected 
by shugoshin (Sgol) by preventing SA2 from being phosphorylated by Plkl 
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(McGuinness eta/., 2005; Kitajima eta/., 2006). Aurora B also regulates the prophase 
pathway, but its exact role is not known. It may recruit Sgo 1 to the centromeric region to 
protect SA2 during prophase. It is not clear how the prophase pathway works. Since most 
ofthe cohesin complexes (not just 'cohesion') are removed from the sister chromatids, it 
is likely that the process involves the opening of the cohesin ring and the 'escape' of the 
sister chromatids in both one-ring and handcuff models. Phosphorylation of SA2 might 
cause conformational change of SA2 which facilitates the opening of the ring. The 
centromeric cohesin complexes and the rest of the arm cohesin complexes are removed in 
the APC/C-Separase pathway at the transition from metaphase to anaphase (Hauf et a/. , 
2001; Haering eta/., 2003). 
Mad1 Bub1 
~ Mad2.,_ Bub3 
Mad3 BubR1 
) 
) 
S-phase Prophase Metaphase Anaphase 
Figure 1.5 APC/C-Separase pathway and prophase pathway (from Panigrahi et al. , 2009). 
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The physiological significance of the prophase pathway is not clear. The APC/C-
Separase pathway alone is sufficient for cleaving all the cellular Rad21 (Kueng et al., 
2006). One possibility for the necessity of the prophase pathway may be facilitating the 
recycling of the cohesin complex. It was found that the cohesin complexes dissociated in 
the prophase pathway are not cleaved by Separase during mitosis and a large portion of 
them re-associate with the cohesin complex in the telophase (Sun et al., 2009; 
Waizenegger, eta/., 2000; Peters et al., 2008). The purpose of the association might be 
related to the transcriptional regulation function of the cohesin complex during 
interphase. For example, the cohesin complex is found to bind to the CCTC-binding 
factor CTCF, which is a transcription regulator (Rubio et al., 2011). If all the cohesin 
complex are cleaved by Separase, the Rad21 will need to be re-synthesized, which might 
lead to the delay of the transcriptional regulation and cause serious consequence for cells. 
1.3 Cohesin and Diseases 
The accurate duplication and segregation are essential for maintaining the genome 
integrity for eukaryotes. Deficiency in any of these processes may potentially cause 
cancer, birth defects and other genetic diseases. Cohesin complex plays an important role 
in regulating the fidelity of the sister chromatid segregation through providing the 
cohesion between sister chromatids and being dissociated from the chromatin in a 
controlled manner. 
Previous studies have shown that the deficiency of cohesin and cohesin-related 
genes are evident in many human cancer and other diseases. Smc3 is overexpressed in 
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human colon cancer cell lines (Ghiselli eta/., 2000). Overexpression of Separase, which 
cleaves Rad21 at the onset of metaphase, in mammary epithelial cells is sufficient to 
induce tumorigenesis in a p53 mutant background in mice (Zhang et a/., 2008). The 
overexpression of Separase might cause the premature cleavage of Rad21, and thus lead 
to aneuploidy. The mutations in Scc2, Smcla and Smc3 can lead to Cornelia de Lange 
syndrome which causes developmental disorders with intellectual disability, skeletal 
abnormality and other developmental deficiencies (Pie eta/., 2010). 
Studying the human cohesin complex at the molecular basis and the role it plays 
in genomic instability will provide insights into our understanding of the mechanism of 
missegregation and contribute to the development of therapeutic methods for cancers and 
other diseases. 
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Chapter II. Cloning, expression, purification and structural 
characterization of SAl by analytical ultracentrifugation 
A robust expression system is essential for preparing the protein of interest for 
structural and functional studies. The human cohesin complex components are likely to 
undergo elaborate folding pathways with post-translational modifications. Therefore, the 
baculovirus expression system, as a eukaryotic expression system, in which insect cells 
are infected by baculoviruses overexpressing the genes of interest, may benefit the 
expression of the human cohesin complex subunits. SA 1/2 is the fourth core subunit of 
the cohesion complex. However, other than its supportive role in chromatin cohesion, 
little is known about its function. Additionally, no structural information on SA proteins 
is available thus far. In humans, SA2 is more abundant than SAl (Losada et al., 2000). 
Therefore, this study mainly focuses on the SA2 protein. 
2.1 Cloning of SA2 into insect cells 
Insect cells allow many sophisticated post-transcriptional modifications similar to 
those observed in higher eukaryotes. The relative simplicity and lower cost of the insect 
cell-baculovirus system make it advantageous over mammalian cell expression system. 
Thus, insect cells were chosen to express the human cohesin complex subunits. A 
schematic illustration of how insect cells can be used to express a protein of choice is 
shown in Figure 2.1. The gene of interest is first cloned into a donor plasmid pFastBac™' 
(Invitrogen) carrying a mini-Tn7 element. The recombinant plasmid is then transformed 
into competent DHIOBac Escherichia coli (E. coli) cells, which contain a bacmid with a 
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Tn7 target site and a helper plasmid encoding a transposon. After the transformation, the 
gene of interest is transposed to the Tn7 target site, leading to the disruption of a LacZa 
gene. Due to this disruption, colonies containing bacmids with the gene of interest 
(positive) have a white appearance in the presence of Isopropyl ~-D-1-
thiogalactopyranoside (IPTG) on an X-gal plate as opposed to the blue appearance of 
colonies containing a functional/acZa gene (negative). Recombinant bacmids are then 
purified and transfected into Spodoptera .frugiperda cell line 21 (Sf21) insect cells in 
order to generate the recombinant viruses overexpressing the gene of interest. Finally, the 
viruses are amplified to reach a higher titer for optimal protein expression. 
To clone SA2, the entire cassette containing the SA2 gene with an HA tag at the 
N-terminus was digested out from 5JJ.g of the pCruz-SA2 construct (pDP871, courtesy of 
Dr. Debananda Pati) with endonucleases Kpnl (NEB) and Sacl (NEB) in NEB buffer 1 at 
37°C overnight. 3JJ.g of the pFastBac™1 vector (Invitrogen) was digested in the same 
manner. Both of the digestion products were purified using a QIAquick Gel Extraction kit 
(Qiagen). The digested SA2 gene product was ligated into the pFastBac vector at 5:1 
ratio with T4 ligase (Roche) at room temperature for 30min. The ligation product was 
transformed into DH5a competent cells (non-commercial) by a 45s heat shock at 42°C 
before the cells were spread onto agar plates (LB + Amp50jiglml) and incubated at 37 °C 
overnight. Colonies were inoculated in a 3ml culture (LB + Amp50jiglml) and the liquid 
cultures were shaken at 250 rpm in a 37°C incubator overnight. Plasmids were purified 
using a QIAquick Miniprep Kit (QIAGEN). Positive clones (clones containing SA2 gene) 
were identified in a 1% agarose gel following a double digestion with Kpni/Sacl. The 
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positive clones were sequenced to verify the proper insertion of the SA2 sequence 
(sequencing was performed by Seqwright, Inc.). 
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Figure 2.1 Schematic flowcharts showing the generation of baculovirus expressing the genes 
of interest (Bac-to-Bac® expression system manual, Version D, Invitrogen). 
The recombinant plasmid containing the coding sequence of SA2 was 
transformed into competent DH 1 OBac E. coli cells (Invitrogen). After being heat 
shocked, DHIOBac cells were shaken at 37°C for 4h and then spread onto X-ga] agar 
plates (LB + KanSO~glml + Tet10~glml + gentamicin7~ml + IPTG40~ gtml + X-gal40~glml). After 
48h of incubation at 37°C, several white colonies were selected and re-streaked onto 
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fresh X-gal plates followed by incubation at 37°C for 48h. Once confirmed by 
restreaking, white colonies were selected and inoculated into a 5ml culture (LB + 
Kan50pgtmi + Tet10pgtmi + gentarnicin711g/mi), which was then vigorously shaken at 37°C for 
16h. Bacmids were extracted using a modified alkaline lysis miniprep protocol as 
described in the Bac-to-Bac® baculovirus expression system manual (Version D, 
Invitrogen). Polymerase Chain Reaction (PCR) with Ml3 forward and reverse primers as 
described in the Bac-to-Bac® baculovirus expression system manual was used to verify 
that the bacmids contained the gene of interest. The size of the extension product was 
found to be -6 kb, consistent with the expected size of the SA2 gene (3.7kb) plus 2.3kb 
(including the gentarnycin resistant gene (Genl), which is reversely orientated in the 
pFastBac vector, and some extra sequence from the bacmid DNA). 
The concentrations of the purified recombinant bacmids were measured using a 
DyNA quant 200 fluorometer (Hoefer). The concentration of a purified bacmid is 
lOOng/J.Ll. To ensure optimal transfection efficiency, approximately 9 x 105 cells Sf21 
cells were seeded per well in a 6-well tissue culture plate (Corning). The plate was then 
incubated at 27 °C for 40min to allow the formation of a monolayer of cells attached to 
the bottom of the wells. For each of the three positive recombinant plasmids selected for 
transfection, 1 J.Lg of DNA and 6J.Ll of Cellfectin® II Reagent (Invitrogen) were 
individually diluted in lOOJ.Ll of on-supplemented Grace's insect cell medium (Sigma-
Aldrich) before they were gently mixed together. The DNA-Cellfectin mixture was then 
incubated at room temperature for 30min. The purpose of this process is to form a DNA-
lipid complex for optimal transfection efficiency. The seeded cells were then taken out of 
the incubator and the attachment of the cells to the bottom of the wells was confirmed 
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using a light microscope (VWR). The medium in each well was discarded and each well 
was washed with 2ml of un-supplemented Grace's medium. For each transfection, the 
200J.ll ofDNA-lipid complex was diluted in 0.8ml ofun-supplemented Grace's medium 
before being added to each well. After incubation for 5h at 27 °C, the un-supplemented 
medium in each well was replaced with 2ml of Grace's medium supplemented with IO% 
Fetal Bovine Serum (FBS; Invitrogen) before incubation at 27°C for 5-7 days. During 
the course of the incubation, the cells were monitored daily for signs of infection, 
including swelling and detaching from the bottom of the well. To harvest the PI virus, 
cells from each well were spun down at 800g for I Omin and the supernatants were saved 
as the PI viral stock. The cell debris remaining in the pellets was examined by SDS-
PAGE to determine the expression level ofthe protein. Cell pellets were resuspended in a 
hypotonic lysis buffer (50 mM Tris-HCl, pH=7.5, 50mM NaCl, 1% Triton X-100 and 
I mM PMSF) and incubated on ice for 30min. The lysates were then centrifuged at 
I8,000g for I5min. The supernatant was electrophoresed on an 8% SDS-PAGE gel and 
subsequently stained in a Coomassie blue solution (Gelcode). A strong band for the HA 
tagged SA2 protein was visible in a Coomassie stained gel, indicating HA-SA2 is 
properly expressed in Sf2I cells and the expression level could be sufficient for structural 
and functional studies. 
For virus amplification, the PI viral stock was used to infect Sf2I cells at a 
multiplicity of infection (MOl} of 0.05 to generate a P2 viral stock and subsequent P3 
viral stock. The titer of each viral stock was determined by plaque assays as described in 
the Bac-to-Bac® Baculovirus Expression System Manual (Version D, Invitrogen). The 
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titer of the P3 viral stock was typically above 1 08 pfulml. The virus stocks were protected 
from light exposure using storage bottles wrapped in foil and stored in a 4°C refrigerator. 
2.2 Purification of HA-SA2 and His-SAl 
To purify HA-SA2 from sf21 cells, ~2 x 109 (or 2 liters) cells were infected with 
the recombinant baculovirus at an MOl of 5 and collected 48h post-infection. The cell 
pellets were then washed with phosphate-buffered saline (PBS; 137rnM NaCl, 2.7rnM 
KCl, 8.1mM Na2HP04 and 1.5rnM KH2P04, pH=7.5). Cell pellets were resuspended in 
35ml ofTris buffered saline (TBS, 50rnM Tris-HCl, 150rnM NaCl, pH=7.5) and lysed by 
sonication using an Ultrasonics Heat Systems sonicator model W-375 at power level 7 
(60% duty cycle) for 3 x 2.5min. The sonication process was performed on ice to prevent 
overheating which might lead to the degradation and denaturation of cellular proteins. 
The cell lysate was then centrifuged at 35,000g for 40min at 4 °C using a Beckman 
centrifuge and the supernatant, which contained >90% of the total HA-SA2, was 
collected for further purification. 
As the first purification step, the ammonium sulfate precipitation method was 
used instead of the more expensive and less efficient immunoaffinity purification using 
anti-HA monoclonal antibody (rnAb) conjugated beads. A small scale ammonium sulfate 
gradient precipitation test was performed to demonstrate that SA2 precipitates at 20% -
30% (w/v) ammonium sulfate concentration. The total volume of the supernatant was 
then measured and ammonium sulfate was added to a final concentration of 20% (w/v). 
The mixture was gently rotated at 4 °C for an hour and the supernatant was obtained after 
a 35,000g x 30min centrifugation. The volume of the supernatant was then measured and 
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ammonium sulfate was added to a final concentration of 30% (w/v), after which the 
mixture was gently rotated for lh at 4°C. The final supernatant was discarded and the 
pellets were resuspended in 30ml of FPLC buffer A (SOmM Tris-HCl, pH=7.5, I mM 
EDT A, 2mM PME, and I mM NaN3). The ammonium sulfate precipitation fractions 
were analyzed by an 8% SDS-PAGE gel. In addition to a ~ 140kD band expected for HA-
SA2, a strong ~ 120kD product was also observed, which might be a degradation product 
of the HA-SA2 protein (Figure 2.2a). To remove any protein aggregates and cellular 
debris that may cause potential harm to chromatography columns, the sample was spun at 
35,000g for 30min and the supernatant was used for subsequent chromatography 
purification. 
To further purify HA-SA2, an ion-exchange column was used. HA-SA2, with a 
theoretical isoelectric point (pi) = 4.27, was loaded onto a Sml Hitrap Q column (GE 
Healthcare) which is an anion exchange column that selectively binds negatively charged 
proteins. Proteins were eluted at an increasing gradient ofNaCl from SOmM to IM at pH 
7.5. HA-SA2 was eluted at about 400mM NaCl. Fractions from the Q column were 
analyzed by an 8% SDS-PAGE gel and the ~120kD product was present in almost every 
fraction that contained the full length SA2 (Figure 2.2 b). 
Samples containing the HA-SA2 protein were concentrated with a centricon tube 
(Millipore) to 2ml before being loaded onto a 120ml Superdex 200 column (GE 
Healthcare ), which is a gel filtration column that separates proteins by molecular weight 
(MW) and shape. HA-SA2 was eluted with a gel filtration buffer (SOmM Tris-HCl, 
200mM NaCl, 10% Glycerol, lmM EDT A, 2mM P-mE, lmM NaN3) at an MW position 
slightly larger than the 150kD MW standard (Figure 2.2c). Fractions from the gel 
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Figure 2.2 Purification of HA-SA2 from insect cells. (a) Fractions from ammonium sulfate 
precipitation. M: molecular weight marker, lane 1, supernatants of the celllysates; lane 2, pellets 
of the cell lysates; lane 3, pellet from precipitated by 20% ammonium sulfate dissolved in FPLC 
buffer A; lane 4, supernatant from 20% ammonium sulfate precipitation; lane 5, supernatant of 
from 30% ammonium sulfate precipitation; lane 6, pellet from 30% ammonium sulfate dissolved 
in FPLC buffer A. (b) Fractions from the Q column. Lane 1, tlowthrough; lanes 2-12, fractions 
eluted from the Q column. Fractions from lanes 5-8 were collected for gel filtration . (c) The gel 
filtration chromatograph and fractions from the gel filtration column. Lane 1, samples from the 
aggregation peak; lanes 2-14, fractions from the major sample peak. 
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filtration chromatogram were analyzed using an 8% SDS-PAGE gel which showed that 
SA2, the -140kD protein, had been co-eluted with the -120kD molecule, although the 
-120kD protein migrated a little slower than the -140kD counterpart. The small 
difference between the MW of the two proteins made it difficult to separate them. 
The failure to purity the full length SA2 protein to homogeneity could have been 
due to the instability of the HA-SA2 protein or alternatively the lengthy ammonium 
sulfate precipitation that might result in protein degradation (Figure 2.2a, Lane 4 vs. Lane 
6). To ease the initial purification process, a six-histidine (6xHis) tag was introduced to 
the N-terminus of SA2 by re-cloning using a 5' primer containing six histidine codons at 
the very 5' end ofthe SA2 eDNA sequence. To insert the gene ofSA2 with a 6xHis tag at 
theN-terminus into the pFastBac™1 vector, a PCR reaction was performed to amplifY the 
SA2 gene. The 50J.1l PCR mixture was composed of O.SJ.ll of template at I Ong/Jll (HA-
SA2), O.SJ.ll ofpfu Turbo polymerase (Stratagene), 5J.1l of 10 x pfu Turbo reaction buffer 
(Stratagene), l.SJ.ll of dNTPs at IOOmM (Promega), 5J.1l of forward primer at lOJ.1M, 5J.1l 
of reverse primer at lOJ.1M, and 32.5J.1l of Milli-Q (MQ) water. The PCR reaction was 
performed in a Mastercycler® Pro S (VWR) PCR machine starting with a Smin 
denaturation step at 94 °C, followed by 30 cycles of denaturation (94°C for 45s), 
annealing (50 °C for 45s), and extension (72°C for 8min). This was followed by a final 
extension step at 72°C for I Omin to ensure complete extension of duplicate DNA strands. 
The PCR product was analyzed by electrophoresis in a 0.8% agarose gel. A DNA 
fragment of approximately 3700 bp was obtained. The PCR product was purified with a 
QIAquick PCR Purification Kit (Qiagen). Both the PCR product and the pFastBac™1 
vector were digested with restriction enzymes BamHI (NEB) and Xhol (NEB) in an NEB 
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buffer at 37 °C overnight. The PCR products were then ligated into the pFastBac™1 
vector. The subsequent cloning procedures were the same as the one described in section 
2.1 for producing higher titer baculoviruses overexpressing the 6 x His tagged SA2. 
To purify the 6xHis tagged SA2, -2 x 108 Sf21 cells were transfected with 
baculoviruses overexpressing His-SA2 and harvested 48h post-infection. Cell pellets 
were resuspended in lOml ofNi-NTA buffer A (50mM Tris-HCl, pH 7.5, 300mM NaCl, 
20mM imidazole, 10% glycerol, O.lmM PMSF) and lysed by sonication. Supernatants 
from the lysates were collected by 35,000g x 40min centrifugation and loaded onto 0.2ml 
of pre-equilibrated Ni-NTA resin (Qiagen). The supernatant was then constantly mixed 
with the resin at 4°C for lb. The resin was collected by l,OOOg x 3min centrifugation and 
the supernatant (flow through) was removed. The resin was then washed with 5ml ofNi-
NT A Buffer A. The proteins bound to the Ni-NT A agarose were eluted by Ni-NT A 
buffer B (50mM Tris-HCl, pH 7.5, 300mM NaCl, 250mM imidazole, 10% glycerol, 
0.1 mM PMSF). The eluted fractions were analyzed by an 8% SDS-PAGE gel (Figure 
2.3a, Lanes 1-5). An -120kD degradation product was also present in the Ni-NTA 
purified fractions. Compared to the initial purification of HA-SA2, the amount of the 
degradation product present decreased significantly. 
The fractions containing the His-SA2 protein were collected and spun down at 
18,000g for lOmin for a complete removal of aggregates and cellular debris. To further 
purify the protein, an anion-exchange column (Figure 2.3a, Lanes 6-12) and a gel 
filtration column were used as described in the purification ofHA-SA2. The sizes ofthe 
columns used were different due to the small scale of the purification performed. A 1 ml 
Q column (GE Healthcare) was used instead of a 5ml Q column and a 24ml Superose 6 
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column was used instead of a 120ml superdex 200 column. The fractions from the gel 
filtration column are shown in Figure 2.3b. The ~ 120kD product was again present in 
every fraction that contained the full length His-SA2. 
(b) M 1 2 3 4 5 6 7 8 9 10 11 12 13 
1~8t~ t~~~ 
100kD I I product 
~--------------------------------~ 
Figure 2.3 Purification of His-SA2 from Sf21 cells. (a) Fractions from the Ni-NTA column and 
the Q column. Lanes 1-5, fractions eluted from the Ni-NTA column; lane 6, flow through from 
the Q column; lanes 7-12, fractions eluted from the Q column. Lanes 10-11 were collected for gel 
filtration . (b) The fractions from the gel filtration column (lanes 1-13). 
l~~~ r Degradation I I prodOO 
~------------------~ 
Figure 2.4 HA-SA2 treated at room temperature for 8 days. Lanes 1-11 were the same 
samples from Lanes 3-13 in Figure 2.3c. 
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2.3 Expression and purification of two SAl deletion mutants 
Crystallization studies require highly pure and homogenous protein samples. The 
full length SA2 proteins purified from section 2.2 contained a degradation product, which 
made the sample impure and unsuitable for crystallization. Hence, it was necessary to 
make a more stable SA2 construct for crystallization studies. 
(a) 
140kD- - His-SA2 FL 
120k0- __ degradation 
product 
l I 
6xHismAb 
(b) 1~1 LMSYR. SLLA GGDDDTMSVI 
1~1 KRKVVEGM L SLTEESSSSD 
1121 LTSTI~RE?K RLRPEDSF!: S VYP. TEHH 
Figure 2.5 Identification of the SA2 degradation product. (a) Western blot of the purified SA2 
full length protein. The 6xHis tag at the N-terrninal of the full length SA2 was detected by 6xHis 
mAb. The - 120kDa degradation product also contained the N-terrninal tag. (b) In-gel digestion 
and peptide identification by HPLC/MS. T 11 22 is the last amino acid identified by MS. The 
peptide coverage at the N-terrninal region is not shown, as the 120kDa product contains the 6xHis 
tag and thus should have all the N-terrninal sequence. 
We found that the ~120kD degradation product ofthe full length SA2 was stable. 
When the fractions from Figure 2.2c (Lanes 3-13) were placed at room temperature for 8 
days and analyzed by an 8% SDS-PAGE gel (Figure 2.4), the full length SA2 was almost 
completely degraded to the ~ 120kD product. The high stability of the ~ 120kD product 
thus made a potentially ideal candidate for crystallization studies. Western blot using the 
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anti 6xHis monoclonal antibody (mAb; BD biosciences) showed that both the full length 
SA2 and the degradation product contained the N-terminal 6xHis tag (Figure 2.5a). 
Therefore, the degradation of SA2 must have occurred near the C-terminus. Mass 
Spectrometry (MS) was used to identify the cleavage site. The -120kD product band was 
isolated from a Coomassie stained gel, washed in MQ water for 3 x 5min and sent to the 
Tufts Core Facility for MS analysis. Peptides from an in-gel digestion by trypsin and 
chymotrypsin were also analyzed by High performance liquid chromatography (HPLC)-
MS and the results showed that amino acids 1-1122 were present (Figure 2.5b), 
suggesting that the cleavage occurred right after T1122, leading to the design of an SA2 
deletion mutant, SA2 (1-1122aa). However, a secondary structure prediction using 
PredictProtein (Rost et al., 2004) showed that there was an extended unstructured region 
flanking the site T1122 (Figure 2.6). Considering that the unstructured region may be 
flexible, thus to cause problems in crystallization, we made two SA2 deletion mutants: 
one is SA2 (1-1122aa), the same as the- 120kD degradation product and the other is 
SA2 (l-1051aa), a slightly shorter construct in which the unstructured region at the C-
terminus was genetically removed. 
Both of the deletion mutants SA2 (1-1051aa) and SA2 (1-1122aa) were 
individually expressed in -2 x 109 S£21 cells and purified using Ni-NTA resin, as well as 
anion exchange and gel filtration columns similar to the purification of the full length 
His-SA2 (Figure 2.7 & Figure 2.8). A 5ml Q column and a Superdex 200 column were 
used in the purification. Both proteins had an apparent MW that was slightly greater than 
150kD (Figure 2.7c & Figure 2.8c). The difference between the theoretical MW 
(-120kD) and the apparent MW from the gel filtration column can either be the result of 
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dimerization, yielding a theoretical MW to ~240kD or a non-spherical shape for both 
mutants. This size issue of SA2 will be addressed in more details in section 4.4. The 
purified SA2 deletion mutants were at least 95% pure as determined by SDS-P AGE 
(Figure 2.7c & Figure 2.8c). Both deletion mutants were then concentrated to 5mg/ml for 
crystallization studies. The concentration was determined using both Bradford assay and 
A2so measurements .. 
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Figure 2.6 Secondary structure prediction for SA2. SA2 amino acid sequence is colored based 
on residue types (e.g. blue for positively charged, red for negatively charged, green for 
hydrophobic, silver for polar, etc). PROF _sec predicts the secondary structure (H = Helix, E = 
strand). Rel_Sec shows the reliability index of the PROF _sec prediction (O=low, 9=high). 
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(a) 
160kD 
120kD 
100kD 
M 1 2 3 4 5 6 7 (b) M 1 2 3 4 5 6 7 8 9 101112 
160k 
_ His...SA2 120k 
(HOS1aa) 100k0 His-SA2 
1· 1051aa) 
1 2 3 4 5 6 7 8 9 10 11 12 
250 ~H~ 
.__ __________ _,
1
1.;051aa) 200 
150 
100 
50 66kD 
40.0 50.0 60.0 70.0 80.0 ml 
-Hjs-SA2 (1 -1051aa) - - MW standard 
Figure 2.7 Purification of SA2 (l-105laa) from Sf21 cells. (a) Fractions from the Ni-NTA 
column. (b) Fractions from the Q column. Lane 1, flow through from the Q column; lanes 2-12, 
fractions eluted from the Q column. Fractions from lanes 6-9 were collected for gel filtration 
purification. (c) The gel filtration chromatogram and fractions from the gel filtration column. 
Lanes 1-12, peak fractions from gel filtration. 
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Figure 2.8 Purification of SA2 (1-1122aa) from insect cells. (a) Fractions from the Ni-NTA 
column. (b) Fractions from the Q column. Lane 1, flow through from the Q column; lanes 2-10, 
fractions eluted from the Q column. Fractions from lanes 5-8 were collected for gel filtration 
purification. (c) The gel filtration chromatogram and fractions from the gel filtration column. 
Lanes l-1 0, peak fractions from the gel filtration column. 
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2.4 Attempts to crystallize the SAl deletion mutants 
Crystallization is a process by which crystals are formed from a macromolecular 
solution. During this process, homogenous molecules form highly ordered three 
dimensional arrays. Protein crystallization is usually a slow process with controlled 
precipitation of proteins in an aqueous solution under the 'assistance' of a precipitant, 
such as ionic compounds or polyethylene glycol (PEG). The process of protein 
crystallization is summarized in Figure 2.9. The target protein is usually mixed with a 
precipitant until it reaches the supersaturated state. In the labile zone, under favorable 
crystallization condition, the primary nucleation of the protein leads to the formation of a 
microscopic crystal nucleus. The micro crystals will then slowly grow into full size 
crystal in the metastable zone. However, if the concentration of the protein is too high, 
the proteins are likely to precipitate or form amorphous aggregates (Ashrie, 2004). 
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Figure 2.9 A schematic phase diagram depicts the protein solubility as a function of 
precipitant concentration (from Asherie, 2004). 
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Protein crystallization is a delicate process where any slight change in the buffer 
condition, temperature or other external factors may result in amorphous aggregates, poor 
crystal quality or no crystal at all. In addition to the external factors, the intrinsic 
properties of the protein sample (e.g., homogeneity, protein stability, flexible region of 
the protein) have large effects on the formation of crystals. 
A large-scale screen is usually the first step in determining the initial 
crystallization conditions. Commercial screening kits (Qiagen, Hampton Research and 
Emerald Biosystems) with conditions varying in salt contents, pH, and the types of 
precipitants were used for the initial crystallization screening. High throughput 
crystallization screening uses 96-well screening trays (Coming), which are designed to 
mimic the sitting-drop method. Each well of the 96-well trays holds I 00 fll of solution 
(i.e., mother liquor) and a small dent in the upper edge of the well accommodates a drop 
of solution composed of an equal amount of the protein and the mother liquor (0.8-1 fll 
each). A Hydra Plus II robot (Rigaku) was used to set up the trays before they were 
sealed by a crystal clear tape to prevent evaporation. In the crystallization trays, vapor 
diffusion is only allowed between the mother liquor and the sitting drop in each well. 
Around half of the drops in each 96-well tray form precipitants when the protein 
concentration is about 5mg/ml for both mutants. 28 trays were set up using both SA2 
mutants at the concentration of 5mg/ml (14 different kits, each condition was repeated 
twice). Unfortunately, no 'hits' were observed in the initial screening of either of the SA2 
deletion mutants. Considering that our collection of crystallization screening solutions 
may not cover a very broad range of conditions, SA2 (l-105laa) was also sent to the 
Hauptman Woodward Research Institute for more crystallization screening. They 
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provided 1536 ctystallization 'cocktail' conditions using microbatch-under-oil method, in 
which a vety small volume of both sample and cocktail solutions were used (200nl 
protein + 200 nl cocktail) without the use of mother liquor (Hauptman Woodward Research 
Institute). However, no ctystals were observed in a 6-week long observation. 
2.5 Limited digestion of the SAl protein 
The SA2 deletion mutants did not ctystallize, perhaps due to the flexibility of the 
molecules. To identify a rigid core of SA2 for ctystallization, the full length SA2 was 
digested with ttypsin and chymottypsin. A ~ 70kD band was observed when 
chymottypsin was used for limited digestion (Figure 2.1 0). However, only a vety small 
amount of this protein ( < less than I 0%) was left in the digested sample, making it 
difficult to purify this ~ 70kD product directly from the digestion product. 
To prepare the ~ 70kD digestion product for ccystallization, the amino acid 
composition of the molecule must be determined for cloning and expression. A Western 
blot using an anti 6xHis antibody showed that the 70kD product had an intact N-
terminus. The molecular weight of the ~ 70kD product was determined accurately by 
matrix-assisted laser desorption/ionization mass spectroscopy (MALDI-MS). Because the 
sequence of His-SA2 is known and the digestion product contains the intact N-terminus 
ofHis-SA2, the cleavage site was then calculated based upon its accurate MW. The total 
MW of His tagged SA2 (1~589aa) matches the MW obtained from MALDI-MS. 
Therefore, the cleavage site was identified as L589• An SA2 mutant containing the first 
587 amino acids of SA2 (SA2 (l-587aa)) was designed excluding the two hydrophobic 
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leucines at the C-terminal that could have negatively affect the solubility of the protein. 
A baculovirus overexpressing SA2 (1-587aa) was constructed. Unfortunately, SA2 (1-
587aa) mostly remained in the insoluble fraction in spite of extensive efforts to solubilize 
the protein in different solvent conditions (Figure 2.10 b). 
(a) 
150kD 
100kD 
70kD 
SOkD 
-His-SA2 
-Degradation 
product 1 
- Degradation 
product 2 
(b) 
70kD 
60kD 
SOkD 
-His-SA2 
(1-587aa) 
Figure 2.10 Identification and expression of the SA2 rigid core. (a) Chymotrypsin 
digestion ofHis-SA2. His-SA2 and chymotrypsin were mixed at the 50:1 mass ratio. Lane 1, SA2 
sample before digestion; lanes 2-5: His-SA2 was digested for 1 min, 5min, 1 Omin and 20min 
respectively. Degradation product 2 was relatively stable when treated with chymotrypsin. (b) 
Purification test for His-SA2 (l-587aa). Sf21 cells expressing His-SA2 (1-587aa) were lysed by 
sonication in different buffer conditions. The odd number lanes represent supernatants of the cell 
lysates while the even number lanes represent cell pellets. All lysis buffers contained: Tris-HCI 
50mM, pH=7.5. In addition, each individual condition contained: lanes 1-2: 300mM NaCl; lanes 
3-4: 200mM (N~)2S04 ; lanes 5-6: 500mM NaCI; lanes 7-8: 400mM LiCI; lanes 9-10: 300mM 
NaCI+l%Giycine; lanes 11-12: 300mMNaCl + IM glucose; Lanes 13-14: 300mMNaCI+60fJ.M 
Tween20. These additional compounds were previously known to enhance protein solubility 
(Bondos et al., 2003). 
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The poor solubility of the SA2 (l-587aa) construct is perhaps due to its inability 
to form a structured domain by itself. It is also possible that the 588-l051aa region is 
important for the correct folding of SA2 (l-587aa) during the expression and post-
transcriptional modification process. It is also possible that SA2 (l-587aa) requires other 
peptides to stabilize it after expression. It appeared that the -70kD protein co-existed 
with two fragments at -30-40kD range (Figure 2.10a). It is possible that the SA2 protein 
was nicked by chymotrypsin at L589, but the SA2 (l-587aa) remained non-covalently 
associated with one or two smaller peptide species, without which, SA2 (1-587aa) can 
not stay soluble. 
2.6 The cloning, expression, purification, and attempts to crystallize more SA2 
deletion mutants 
Since our rational design of the SA2 core, SA2 (1-587aa), failed, we decided to 
employ a systematic approach to search for an SA2 deletion mutant that is soluble and 
can be used for crystallization. 
Baculovirus overexpressing progressive SA2 deletion mutants with ISO amino 
acids increments/decrements from either the N- or the C-terrninus of SA2 (l-1051aa) 
were generated (Figure 2.lla). In addition to the above deletion mutants, baculovirus 
overexpressing SA2 (1 052-1231 aa) was also obtained. To evaluate the expression level 
and solubility of the various SA2 deletion mutants, the cell pellets separated from the PI 
viral stocks were lysed with a hypotonic lysis buffer as mentioned in section 2.1 and the 
resulting supernatants were analyzed by western blot using an anti 6xHis mAb. The 
results showed a relatively high expression level of soluble proteins for the deletion 
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mutants: SA2 (l-150aa), SA2 (1-302aa), SA2 (l-750aa), SA2 (1-903aa), SA2 (451-
1051aa), SA2 (581-105laa), and SA2 (1052-123laa). These baculoviruses were used for 
further amplification. Approximately 2 x I 08 sf21 cells were infected with baculoviruses 
overexpressing each of the deletion mutants mentioned above at an MOl of 5. Each of the 
deletion mutants were purified in the order ofNi-NTA column, anion-exchange, and gel 
filtration columns. The fractions from the gel filtration for each mutant are shown in 
Figure 2.llb. Among all the deletion mutants tested, only SA2 (l-302aa) and SA2 (451-
1051 aa) had sufficient yields for crystallization study. 
( a )pHis-SA2 (b) 1-1 50 
1-1231aa 
1052-1231aa I 1-1051aa 1-302 
1-150aa 
1-302aa 1-750 
1-450aa 
1-587aa 
1-750aa 1-903 
l -903aa 
-I 151 -1051aa 451-1051 
303-1051 aa 
451 -1051 aa 581-1051 581-1051aa 
751- 1051 aa 
---- 1 904-1051 aa 1052-1231 
Figure 2.11 Purification test for SA2 deletion mutants. (a) Schematic figure of the SA2 
deletion mutants. (b) Fractions from gel filtration for each of the SA2 deletion mutants were 
analyzed by SDS-PAGE gels. SA2 (l-302aa) and SA2 (451-105laa) displayed high yield suitable 
for crystallization studies. 
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For preparative scale purification, SA2 (l-302aa) and SA2 (451-105laa) were 
purified from -2 x 109 cells each as described in section 2.2. The gel filtration 
chromatograms are shown in Figure 2.12. The apparent MW of SA2 (l-302aa) is 
-1 OOkD, indicating the formation of a spherical trimer or a monomer/dimer with non-
ideal shapes. The final purified SA2 (l-302aa) sample contained a contaminating -25kD 
protein (Figure 2.12a), which might cause some problem in crystallization. In addition, 
the (l-302aa) protein quickly precipitated at both 4°C and room temperature. 
The gel filtration chromatogram showed that SA2 (451-105laa) was eluted in 
three forms (Figure 2.12b). By comparing the chromatogram to the MW standard, the 
three forms are most likely tetramer, dimer and monomer, among which, the dimer was 
most dominant. Fractions containing the dimer were collected and concentrated to 5 
mglml for crystallization screenings. Crystallization screenings were both performed in 
the lab and at the Hauptman Woodward Research Institute. Unfortunately, the protein 
precipitated heavily, even at 2mg/ml and no crystals were observed. 
2.7 The cloning, expression, purification, and attempts to crystallize the SAl protein 
The human SA 1 protein shares 70% sequence identity with its ortholog SA2. 
Considering that SA 1 may be a better crystallization target, baculovirus overexpressing 
the 6xHis tagged SAl protein was generated and the purification of SAl was performed 
as described in 2.2. Resembling SA2, SAl produced a -120kD degradation product 
during the purification process (Figure 2.13 a,b ). An in-gel digestion by chymotrypsin 
followed by an MS analysis showed that the degradation occurred near T1123, which is 
conserved and equivalent to the previously identified T1122 of SA2 (Figure 2.14). 
42 
(a) 
mAU 
250 
200 
150 
100 
50 
0 - - - - -- - ·-
40.0 45.0 
(b) 
mAU 
500 
50.0 55.0 60.0 
- · His-SA2(1-302aa) 
His-SA2 (451 -1051aa) 
His-SA2 (1 -302aa) 
-His-SA2 
(1-302aa) 
65.0 70.0 75.0 
- - -- MW standard 
80.0 ml 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
His-SA2 
-1051aa) 
400 
300 
200 
100 
0 
40.0 
. .,..- ...... . ... 
_i 
50.0 
, 
, 
60.0 
• ! 
..... ~" 
-.... ..... ; .. -·· -·-·-·""· 
70.0 80.0 90.0 ml 
-His-SA2(451-1051aa) -· - .. MW standard 
Figure 2.12 Purification ofHis-SA2 (1-302aa) and His-SA2 (451-1051aa). (a) Gel filtration 
chromatogram for His-SA2 (1-302aa) and fractions from the gel filtraion (lanes 1-10). (b) Gel 
filtration chromatogram for His-SA2 (451-105laa) and fractions from the gel filtraion (lanes 1-
14). 
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Figure 2.13 Purification of His-SAl from Sf21 cells. (a) Fractions from the Q column. Lane 1, 
flowthrough from the Q column; lanes 2-9, fractions eluted from the Q column. Fractions from 
lanes 5-7 were collected for gel filtration purification. (b) Fractions from the gel filtration column. 
Lanes 1-10, peak fractions from gel filtration. 
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SA2 1001 ----DILSEF SSKLLRQDKR TVYVYLEKFM TFQMSLRRED 1036 
SA1 1001 LAFLEVLSEF SSKLLRQDKK TVH SYLEKFL TEQMMERRED 1040 
SA2 1037 VWLPLMSYRN SLLA DOD T MSVI S - I SS R STVRSKKS 1075 
SA1 1041 VWLPLI SYRN SLVT EDDR MSV . ~ S ssss KTSSVRNKK 1080 
SA2 1076 KPST KRKVV E MQLSLTEE SSSSOSMWL S R- EQTLHTPV 1114 
SA1 1081 RPPLHKKRVE 0--------- - ESLD T WLt RTDTMI QTPG 1110 
SA2 111 5 MMQTPQLTST IMRE PKR--- ---L ED -- ----SFMSVY 1142 
SA1 1111 PLPAPQLTST VLRE NSRPM DQI QEPESEH GSEPDFLHNP 1150 
SA2 1143 PMQTEHHQTP --LDYNRR T s--------- --------LM 1163 
SA1 1151 QMQI SWL QP KLED LNRKDR T MNYMKVRT VRHAVR LM 1190 
SA2 1164 EDDEE PIVED VMMSS E RI E DLt- E MOFD T MDI DLPP SK ~ 1203 
SA1 1191 EEO EP I FED VMMSS RSQLE OM! EE FE- OT MVI OLPP SRN 1229 
SA2 1204 RRERTELKPD FFDPASIM- D ESVL..,VSMF 1231 
SA1 1230 RRERAE LRPD FFDSAAIIED OS F MF 1258 
Figure 2.14 Alignment of the C-terminal sequences of SA2 and SAl. T 1122 from SA2 is 
conserved to T 1123 from SAL G10s1 from SA2 is conserved to G 1oss from SAl. The sequence 
alignment was prepared using BioEdit (Hall, 1999). 
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Furthermore, G1oss of SAl is also conserved and equivalent to G10s1 of SA2. Like SA2, 
the SAl 1056-1123aa region mainly consists ofnon-structured coils, which may increase 
the flexibility of the protein. Therefore, baculovirus overexpressing the SA 1 deletion 
mutants SAl (l-1123aa) and SAl (l-1055aa), the latter of which lacks the flexible 
region, were generated. SAl (l-1123aa) showed signs of degradation in a small scale 
purification test (data not shown). Therefore, only the SAl (l-1055aa) was purified in 
larger amounts as described in section 2.2 (Figure 2.15). Like SA2 (1-105laa), SAl (l-
1055aa) was also eluted with an apparent MW slightly greater than 150kD. SAl (1-
1055aa) was then concentrated to 5 mglml and crystallization screenings were performed. 
Unfortunately, no micro crystals were obtained. 
2.8 Analytical ultracentrifugation studies of the SAl protein 
Since the crystallization study of the SA2 protein was not successful, we decided 
to take another approach to obtain structural information for the SA2 proteins. Analytical 
Ultracentrifugation (AU) was used to address two questions. First, it was mentioned in 
section 2.3 that SA2 (l-105laa) was eluted from the gel filtration column at a position 
indicating an apparent MW larger than 150kD. However, it was previously reported that 
there was only one SA2 molecule existed in each cohesin complex in vivo in both the 
one-ring model and the handcuff model (Haering et al., 2002; Zhang et al., 2008). By 
measuring the MW of SA2 using the AU method, we can find out if it forms dimer in 
insect cell system. Second, the difficulty in crystallization may indicate that the SA2 
molecule is largely flexible and its shape is far from being ideal. AU experiments may 
also provide some information on the shape of the SA2 molecule. 
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Figure 2.15 Purification of His-SAl (1-1055aa) from St21 cells. (a) Fractions from the Q 
column. Lane 1, flowthrough from the Q column; lanes 2-13 , fractions eluted by the Q column. 
Fractions from lanes 7-11 were collected for gel filtration purification. (b) Fractions from the gel 
filtration column. Lane 1, fraction from aggregation peak; lanes 2-10, peak fractions from gel 
filtration. 
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AU is a spectroscopic technique, in which a protein sample is spun at a controlled 
speed and constant temperature. The absorbance of the sample is measured at a given 
wavelength along the radius of the rotor cells. The concentration distribution of the 
sample along the cell radius is then determined. There are two AU methods: 
sedimentation velocity (SV) and sedimentation equilibrium (SE). SV experiments are 
performed at a relatively higher speed and for a shorter time for the sedimentation of the 
samples to the bottom of the cells. SE experiments are performed at a relatively lower 
speed and for a longer time for the samples to reach a concentration distribution 
equilibrium, in which the force of sedimentation and diffusion acting on the samples are 
balanced (Demeter, 2010). SE experiments can accurately determine the molecular 
weights of macromolecules in solution regardless of their shapes. However, the long 
running time required may cause aggregation and/or the degradation of the protein 
samples, thus adversely affecting the reliability of the obtained data. SV experiments, 
when combined with the Ultrascan software as a powerful data analyzing tool (Uitrascan 
(Demeter, 2005), http: //www.ultrascan.uthscsa.edu), can obtain most of the information 
traditionally obtained from SE experiments based upon the formulas shown in Figure 
2.16. SV experiments also avoid the long running time required for SE experiments. 
Therefore, SV experiments were used to analyze our samples. 
SV experiments were performed for the purified SA2 (1-1051aa) sample using a 
Beckman Coulter Optima XL-A analytical ultracentrifuge. To determine the MW ofSA2 
(l-1051aa), data were collected at two different optical density (OD) values, which were 
obtained against a water reference at 230nm. The sedimentation velocity experiments 
were performed at 36,000rpm (AN60 Rotor) and 4°C for 15h. One hundred and fifty 
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Figure 2.16 Formulas for the data analysis of sedimentation velocity experiments (Adapted 
from Demeter, 2005). (a) The relationship between Distribution of the sample concentration (C) 
along the radius of rotor cells (r) at certain time (t), the sedimentation ofthe sample (blue circle) 
and the diffusion of the sample (red circle). S: sedimentation coefficient; ro: angular velocity ; D: 
diffusion coefficient. (b) k is defined as the ratio between frictional ratio of the sample (t) and 
frictional ratio of the solvent (f0). (c-t) the relationship between D, M (molecular weight of the 
sample), k, sand f. 
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Figure 2.17 G(s) for SA2 (l-105laa) at different concentrations. 
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scans were recorded for each sample at a radial step size of 30p.m. Data analysis was 
performed with UltraScan version 9.9 (Ultrascan (Demeler, 2005}, http: 
//www.ultrascan.uthscsa.edu). Time invariant noise and radially invariant noise were 
subtracted from the sedimentation velocity data by 2-dimentional spectrum analysis 
(Brookes et a/., 2010; www.uslims.uthscsa.edu). The Gaussian distributions of the 
sedimentation coefficient (G(s)) were obtained with enhanced van Holde-Weischet 
analysis using Ultrascan (Demeler et a/., 2004). The van Holde-Weischet integral 
distribution plot showed that the distributions of the sedimentation coefficient for both 
samples are identical (Figure 2.16). This suggests no oligomerization occurred during the 
data collection. A global generic algorithm Monte Carlo analysis was also performed 
(Cao eta/., 2008) to determine the molecular weights and compositions of the samples. 
The results showed that there was only one major species displaying a molecular mass of 
108.6 (108.2, 109.3) kDa and a frictional ratio of 1.66 (1.65-1.67: 95% confidence 
intervals). Compared to the theoretical MW of 120kD for monomer and 240kD for dimer, 
the result showed that SA2 (l-1051aa) was purified from Sf21 cells as monomer, 
consistent with both ofthe cohesin models. The frictional ratio of 1.66 suggests that SA2 
(1-1051aa) is likely to be an elongated molecule. 
2.9 Future direction for the structural studies of the SA2 protein 
The AU experiment has answered two questions. First, SA2 (1-1051aa) forms 
monomer, which is consistent with both the one-ring and handcuff model (Gruber eta/., 
2003; Zhang et a/., 2008). Second, SA2 (l-1051aa) is likely an elongated molecule, 
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suggesting it might contain one or multiple flexible regions. This might increase the 
difficulty in crystallization. 
To obtain more information of the SA2 protein, we performed a domain 
prediction using GlobPlot (Linding et al., 2003). The prediction result showed that theN-
terminal 75aa of SA2 formed disordered structures, which might be one of the reasons 
that the crystallization studies of SA2 (1-1051aa) and SA2 (1-1122aa), both of which 
contained the disordered domain, were not successful. For SA2 (451-lOSlaa), the N-
terminus of this construct did not contain any disordered sequences. However, the C-
terminal 982-lOSlaa contained some disordered sequences. The predicted disordered 
regions in the SA2 molecular might play a role in increasing the difficulty of 
crystallization. 
In the future, improved schemes can be used in the structural studies of the SA2 
protein as described below. 
First, globular structural prediction information will be integrated in the design of 
SA2 mutants. New constructs should exclude the unstructured domains indicated by the 
globular domain prediction. 
Second, after new crystallization targets are identified (i.e., the SA2 mutants that 
can be purified in large amount), in addition to the crystallization studies, AU 
experiments will be performed to access the information of the shape of the molecules. 
For smaller SA2 deletion mutants, circular dichroism (CD) spectroscopy experiments can 
also be performed to obtain secondary structure information of the molecules. 
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Figure 2.18 Glotplot for the human SA2 protein. Underlined sequences are predicted to be 
disordered. 
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Third, because SA2 is known to interact with Rad21 in the cohesin complex 
(Haering et al., 2002), the interaction domain of SA2 and Rad21 will be determined, and 
the complex composed of the interaction domains of the two proteins can be used for 
structural studies. Other than Rad21, PdsS and Wapi are also shown to interact with SA2 
(Rowland et al., 2009). A complex with one of these cohesin associated proteins is also a 
future direction for the structural characterization of SA2. 
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Chapter III. The cloning, expression, purification and attempts to study 
the structure ofRad21 
Rad21 connects the NBD heads of Smcl and Smc3 via its C- and N-terminal 
domains to form the cohesin ring (Haering eta/., 2002; Gruber eta/., 2003). It is also the 
only protein among the three to interact with the fourth cohesin 'core' subunit, SAI/2 
(Haering eta/., 2002; Gruber eta/., 2003). Rad21 is cleaved by a thiol protease, Separase, 
during the transition from metaphase to anaphase to ensure the complete dissociation of 
the cohesin complex from sister chromatids (Uhlmann eta/., 1999; Hauf eta/., 2001). 
The only known structural information about Rad21, or its homolog, is the C-terminal 
115 amino acids of the yeast Rad21, which forms a complex with the NBD of Smc I 
consisting of Smcl 's N- and C-termini connected by a peptide linker (Haering eta/., 
2004 ). Studying the structure of human Rad21 will provide more information on the 
formation of the cohesin ring and its interaction with other subunits. It will also provide 
information on whether two Rad21 molecules interact with each other in an anti-parallel 
manner according to the previously proposed handcuff model (Zhang eta/., 2008). 
3.1 The cloning and expression ofRadll and its deletion mutants in insect cells 
The Flag-tagged Rad21 gene was cut from S~g of pFlag CMV2 Rad21 plasmid 
(courtesy of Dr. Debananda Pati) with Sacl and Kpnl and ligated into the pFastBac vector. 
Baculovirus overexpressing the Flag tagged Rad21 was then obtained as described in 
section 2.1. The cell debris from the PI virus was analyzed by both Coomassie stained 
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SDS-P AGE and western blot to determine the expression level of the Rad21 protein. The 
expression of Rad21 was only detected by western blot but not on a Coomassie stained 
gel. Therefore, the amount obtained was insufficient for crystallization studies. 
(a) (b) 
pFiag-Rad21 
1-631 aa 100kD-
1-172aa -Rad21 (171-631aa} 
171-450aa SOkD-
-Rad21 (171-450aa} 
451-631 aa 37kD-
-Rad21 (451-631aa) 
1-450aa 
171-631 aa 
Figure 3.1 Construction and expression of the Rad21 deletion mutants. (a) Schematic figure 
of the Rad21 deletion mutants. (b) Western blot for Rad21 (171-450aa), Rad21 (451-63laa) and 
Rad21 (171-631aa). Rad21 (171-631aa) showed signs of degradation during expression. 
To identify a Rad21 deletion mutant that was suitable for crystallization studies, 
five Rad21 deletion constructs were designed based upon the Separase cleavage sites 
located at R172 and R450 in human Rad21 (Hauf eta/. , 2001 ; Figure 3.la). Baculoviruses 
overexpressing each of the deletion mutants with a Flag tag at the N-tenninus were 
generated and the expression levels were tested for each mutant. Among the five deletion 
mutants, Rad21 (1-172aa) and Rad21 (1-450aa) were only detectable by western blot, 
while Rad21 (171-450aa), Rad21 (451-63laa) and Rad21 (171-63laa) could be clearly 
visualized on Coomassie stained gels. 
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Among the three Rad21 mutants with high expression levels, Rad21 (171-631aa) 
showed signs of degradation during expression (Figure 3.1 b), indicating that it is not a 
stable protein, and that it is not suitable for crystallization. Therefore, only Rad21 (171-
450aa) and Rad21 (451-631aa) were tested for purification. In addition, Flag tagged 
Rad21 (280-450aa) was also constructed based upon the apoptosis cleavage site at 0 279 
(Pati eta/., 2002). 
3.2 Molecular weights of Rad21 and its deletion mutants 
The theoretical MW of human Rad21 is 70kD, but it migrated on a denaturing 
SDS-PAGE gel with an apparent MW of -120kD. The Rad21 proteins from other 
organisms also have a much larger MW than predicted (Guacci et a/., 1997). The 
observed MWs of the Rad21 deletion mutants were also found to be larger than their 
theoretical MWs at similar proportions (Table 3.1 ). The cause of the slow migration of 
Rad21 and its deletion mutants on an SDS-PAGE gel is unknown. 
3.3 Purification of the Rad21 deletion mu1ants from Stll cells 
Ammonium sulfate precipitation is a cheaper and more convenient method to 
purify Flag tagged Rad21 compared to using anti-Flag M2 affinity resin (agarose beads 
conjugated with anti-Flag monoclonal antibody). The three Rad21 deletion mutants that 
expressed well were first used for a small scale ammonium sulfate precipitation gradient 
test to determine the amount of ammonium sulfate needed to precipitate the proteins. 
From the test, I found that Rad21 (171-450aa) precipitated along with other proteins 
throughout a wide range of ammonium sulfate concentrations. Therefore, ammonium 
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sulfate precipitation was not a suitable method for the purification of this particular 
construct. Both Rad21 (451-631aa) and Rad21 (280-450) precipitated at 20% ~ 30% (w/v) 
ammonium sulfate concentration. Each of these two deletion mutants was purified 
subsequently. 
Rad21 construct Calculated MW Apparent MW (MW app; kD) MW app/MW cat (MWca~; kD) 
Full length (63laa) 72.9 120 1.65 
l-450aa 52.3 80 1.53 
l-172aa 21.0 30 1.43 
171-63laa 53.4 90 1.69 
171-450aa 32.8 50 1.52 
451-63laa 21.9 40 1.83 
Table 3.1 Comparison between the apparent MW and calculated MW of Rad21 and its 
deletion mutants. 
Rad21 ( 451-631 aa) was expressed in approximately 1 x 109 Sf21 cells. The 
theoretical pi for Rad21 ( 451-631 aa) is 4.6. Therefore, a Hitrap Q column, which is an 
anion exchange column, was used as a following purification step using the Rad21 ( 451-
631 aa) sample collected from ammonium sulfate precipitation. Rad21 ( 451-631 aa) was 
eluted from the Q column at 350mM NaCl (Figure 3.2a). The resulting fractions were 
collected, concentrated, and diluted in FPLC buffer A to reduce the salt concentration to 
about I OOmM NaCl before the sample was loaded onto a 5ml Heparin column. A broad 
peak was observed in the Heparin chromatogram together with some unbound Rad21 
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( 451-631 aa), indicating the affinity of Rad21 ( 451-631 aa) bound to the heparin column 
was weak (Figure 3.2b). Fractions from the heparin column were then collected, 
concentrated, and loaded onto a Superdex 200 column. Fractions from the Superdex 200 
column were analyzed by Coomassie blue stained SDS-PAGE (Figure 3.2c). Judging 
from the intensities of the protein bands on the Coomassie blue stained gel, there were 
two 'peaks' (Figure 3.2c, lane 4 and lane 11). The first peak, indicated by the left arrow 
in Figure 3.2c, contained aggregated proteins. The second peak, indicated by the middle 
arrow in Figure 3.2, contained a protein whose apparent MW was around lOOkD. The 
theoretical MW of Rad21 (451-63laa) is -20kD, suggesting the Rad21 (451-63laa) 
protein existed as an oligomer in the second peak. The gel filtration chromatogram also 
had a third peak, indicated by the right arrow in Figure 3.2c, whose suggested MW was 
smaller than 66kD. However, the proteins from this peak had very low concentrations, as 
shown by Coomassie gel (Figure 3.2c, lane 17), and the proteins represented may not be 
the Rad21 (451-63laa) monomer. Indeed, they likely come from the 'shoulder' of the 
second peak, as the shape of the third peak appeared to be too abrupt for a normal protein. 
Regardless of the third peak represents the monomer or not, the amount of protein present 
in either peak two or peak three was insufficient for crystallization studies. 
Rad21 (280-450aa) (pi= 5.1) was also expressed in -1 x 109 Sf21 cells. After the 
Rad21 (280-450aa) sample was precipitated by ammonium sulfate, it was loaded onto a 
5ml Q column, from which it was eluted at 400mM NaCl (Figure 3.3a). Fractions 
containing Rad21 (280-450aa) were loaded onto a superdex200 column and the 
subsequent fractions obtained were analyzed by Coomassie blue stained SDS-PAGE. 
Both the gel filtration chromatogram and the Coomassie stained gel showed that most of 
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Figure 3.2 Purification of Flag tagged Rad21 (451-631aa) from insect cells. (a) Fractions from 
the Q column. Lane I, flowthrough from the Q column; lanes 2-11 , fractions eluted by the Q 
column. Fractions from lanes 6-9 were collected for the heparin column. (b) Fractions from the 
heparin column. Lane 1, flowthrough from the heparin column; lanes 2-11 , fractions eluted by the 
heparin column. Fractions from lanes 4-9 were collected for gel filtration. (c) The gel filtration 
chromatogram ofRad21 (451-63laa) and eluted fractions from the column. Lane 1, concentrated 
samples before being loaded onto the gel filtration column; lanes 2-18, fractions from the gel 
fil tration column. 
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the Rad21 (280-450aa) was eluted as aggregates (Figure 3.3b left arrow and lane 1). 
There was also a very small amount of the sample that was eluted at a position indicated 
by the right arrow in Figure 3.3b, whose apparent MW was less than 66kD. This could 
correspond to Rad21 (280-450aa) monomer or dimer. However, the amount was 
insufficient for crystallization studies. 
Ammonium sulfate precipitation was not an effective initial step to purify the Flag 
tagged Rad21 (171-450aa). To aid in the purification of Rad21 (171-450aa), a new 
Rad21 (171-450aa) construct with a 6 x His tag at theN-terminus was engineered for the 
baculovirus system. To express the 6 x His tagged Rad21 (171-450aa) (pi=4.4), -1 x 109 
Sf21 cells were infected with baculovirus overexpressing Rad21 (171-450aa). Cells were 
harvested 60h post-transfection and the supernatants obtained from the cell lysate were 
passed through 1ml of Ni-NTA resin to purify the 6 x His tagged Rad21(171-450aa) 
(Figure 3.4a, lanes 1-6). In the fractions containing Rad21 (171-450aa), two upper bands 
were also present. Therefore, the fractions containing the Rad21 (171-450aa) were loaded 
onto a Sml Q column, and the protein was eluted at 400mM NaCI. Fractions eluted from 
the Q column containing Rad21 (171-450aa) were then loaded onto a 1ml Heparin 
column. Neither the Q column nor the Heparin column was able to separate Rad21 ( 171-
450aa) from the two upper bands. The fractions from the Heparin column were loaded 
onto a Superose 6 column. However, most of the protein was eluted as aggregates (Figure 
3.4c, left arrow). In addition to the large aggregation peak, there was a small peak, 
indicated by the right arrow in Figure 3.4c, showing that the protein was eluted with an 
apparent MW larger than 150kD. Given that Rad21 (171-450aa) has a theoretical MW of 
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Figure 3.3 Purification of Flag tagged Rad2l (280-450aa) from insect cells. (a) Fractions from 
the Q column. Lane 1, flowthrough from the Q column; lanes 2-13, fractions eluted from the Q 
column. Fractions from lanes 8-12 were collected for the heparin column. (b) Gel filtration 
chromatogram for Rad21 (280-450aa) and fractions from the gel filtration column. Lane 1: 
fraction from the aggregation peak (left arrow). Lane 2-12, consecutive fractions collected after 
the aggregation peak. Lanes 6-8 were fractions collected around the right arrow. 
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Figure 3.4 Purification ofRad21 (171-450aa). (a) Fractions from the Ni-NTA column and the 
Q column. Lanes 1-6, fractions eluted by the Ni-NTA column; lane 7, tlowthrough from the Q 
column; lanes 8-14, fractions eluted by the Q column. Lanes 9-11 were collected for the heparin 
column. (b) Fractions from the heparin column. Lane 1, tlowthrough from the heparin column; 
lanes 2-13, fractions eluted by the heparin column. Lanes 4-9 were collected for gel filtration. (c) 
Gel filtration chromatogram for Rad21 (171-450aa). 
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33kD, this peak may represent an oligomer of the protein. However, the amount of this 
oligomer present was too little for crystallization studies. 
The full length Rad21 has been shown to be a 'sticky' protein. When it was co-
purified with SA2 (451-105laa), the complex was eluted mostly as aggregates. SA2 
(451-105laa) can be purified alone without it forming large aggregates (Figure 2.11). 
Therefore, it is likely that the aggregation of Rad21 caused the aggregation of the 
complex. Indeed, all three Rad21 deletion mutants that I have tested, including Rad21 
(451-63laa), Rad21 (171-450aa}, and Rad21 (280-450aa) mostly form aggregates during 
purification. In vivo, Rad21 should not form large aggregates, as unregulated aggregation 
of Rad21 would result in the aggregation of the cohesin complex and thus lead to the 
aggregation of the chromosomes, which would be detrimental to cell survival. There are a 
few possible causes for the nonspecific aggregation of human Rad21 in insect cells. First 
of all, the expression of Rad21 and its binding to the cohesin complex in vivo may be 
regulated by other human proteins that are missing from insect cells. Another possibility 
could be that some proteins in the insect expression system may cause the aggregation of 
Rad21 proteins by an unknown mechanism. The E. coli expression system was then used 
as described below to test this possibility. 
3.4 The cloning and expression of Radll deletion mutants in E. coli 
Compared to insect cells, the E. coli expression system is less costly and labor 
intensive. However, it does not provide the post-translational modifications in eukaryotic 
cells. Therefore, E. coli was used to express some of the shorter Rad21 deletion 
constructs, the folding pathway of which might not be as elaborate the longer Rad21 
constructs. 6xHis tagged Rad21 (451-631aa) and Rad21 (280-450aa) were cloned into the 
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pET28b vector and transformed into Rosetta competent cells. The temperature, time of 
induction, and IPTG concentration were then varied to determine the optimal expression 
of each protein. 
Rad21 (451-63laa} was optimally expressed at 30°C with O.lmM IPTG for 4h. 
Because the Rad21 (451-63laa) construct carries a 6xHis tag at theN-terminus, Ni-NTA 
resin was used for the initial purification step. However, most ofRad21 (451-631aa) did 
not bind to Ni-NT A resin, indicating that the N-terminal 6xHis tag might be "buried" in 
the molecule (Figure 3.5a). In addition, there was a -70kD protein present in each 
fragment eluted from the Ni-NTA resin. The -70kD band was not detected by an anti-6 x 
His mAb or anti Rad21 mAb (Sigma-Aldrich}, suggesting that it was an E. coli protein, 
possibly GroEL, a host chaperonin that is often associated with poorly folded proteins. 
Alternatively, it could be a cellular protein with a strong Ni-NTA binding affinity. This 
protein was also present in the same fractions as Rad21 (451-63laa) when they were 
eluted from a Q column. The amount of the unknown protein is much larger than that of 
Rad21 (451-63laa) (Figure 3.5b). The 6 x His tagged Rad21 (280-450aa) was also tested 
using the same method. Similar to Rad21 (451-63laa}, the binding affinity of 6 x His 
tagged Rad21 (280-450aa) to the Ni-NT A beads was low and once again the -70kD band 
was dominant in the fractions obtained from the Q column. Given the low efficacy ofNi-
NT A purification under natural condition, alternative approaches were required to be 
tested in order to purify the Rad21 deletion mutants expressed E. coli. 
For both Rad21 (451-63laa) and Rad21 (280-450aa}, around 40o/o-50% of the 
expressed proteins were found in inclusion body after cell lysis. Therefore, the proteins 
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could potentially be purified from the inclusion bodies under denaturing condition and 
then refolded to their native state. 
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Figure 3.5 Purification of Rad21 (451-63laa) from E. coli under native condition. (a) 
Fractions from the Ni-NTA resin. Lane 1, supernatant; lane 2, cell pellet; lane 3, tlowthrough 
from the Ni-NTA column; lane 4, wash; lanes 5-10, fractions eluted from the Ni-NTA column. (b) 
Fractions from the Q column. Lane 1, tlowthrough from the Q column; lanes 2-6, fractions from 
the Q column. 
There are two different ways to prepare the solution containing the denatured 
protein. The first way is to lyse the cells directly in 8M urea and collect the supernatants 
for Ni-NTA purification. The alternative way is to lyse the cells in Ni-NTA buffer A and 
resuspend the pellets in 8M urea for Ni-NT A purification. The first method is easier to 
perform while the second method might generate higher purity of sample. Both methods 
were individually tested using 200ml of E. coli cells overexpressing Rad21 ( 45 1-631 aa). 
Two solutions containing the denatured proteins, each prepared using one of the above 
two mentioned methods were loaded onto I ml Ni-NT A resin respectively before being 
mixed at 4°C for lh. Ni-NTA resin was collected by centrifuging the samples at IOOOg x 
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5min. The resin was then washed with wash buffer (50mM Tris-HCI, 8M Urea, pH=6.3). 
This step was to remove any nonspecifically bound proteins. The bound proteins were 
then eluted using elution buffer 1 (50mM Tris-HCI, 8M Urea, pH=5.9) and elution buffer 
2 (50mM Tris-HCI, 8M Urea, pH=4.5). All ofthe fractions obtained were analyzed by 12% 
SDS-PAGE gels. The second method yielded Rad21 ( 451-631 aa) at a much higher purity 
than the first method (Figure 3 .6). Rad21 ( 451-631 aa) was eluted mostly by elution 
buffer 2 for both methods, indicating a high binding affinity of the denatured protein to 
the Ni-NTA beads. 
With the above encouraging results, I then performed Rad21 purification at a 
large scale. Rad21 ( 451-631 aa) was expressed in approximately 600ml of E. coli cells 
and purified using the second method as described above. The fractions containing the 
purified Rad21 ( 451-631 aa) showed -95% purity which is sufficient for gel filtration 
purification. However, it needed to be refolded before being loaded onto the superdex200 
column. The protein was refolded using a refolding buffers (pH=8.2) containing 50mM 
Tris-HCI, 20mM NaCI, 0.8mM KCI and varying amount of guanidine and arginine. A 
large amount of precipitation was observed during the course of refolding under each 
condition. Among these, the condition containing 0.4M arginine generated the least 
amount of precipitation. After refolding, the Rad21 ( 451-631 aa) sample acquired 
additional band on SDS-PAGE gel at the -llOkD position. This was approximately three 
times as large as the MW ofthe Rad21 (451-631aa) monomer, suggesting the formation 
of a trimer (Figure 3.7b, Janel vs. lane2), the cause of which is unknown. The 
precipitation was removed by a 35,000g x 30min centrifugation and the supernatant was 
loaded onto the Superdex 200 column. The fractions eluted from the Superdex 200 
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Rad21 ( 451-631 aa) 
Figure 3.6 Purification test of 6 x His tagged Rad21 (451-63laa) using Ni-NTA resin under 
denaturing condition. (a) Ni-NT A purification using the fi rst method as mentioned in section 
3.4. Lane 1, supernatant; lane 2, cell pellet; lane 3, tlowthrough from the Ni-NTA column; lanes 
4-6, wash; lanes 7-10, fractions eluted by elution buffer 1; lanes 11-13, fractions eluted by elution 
buffer 2. (b) Ni-NTA purification using the second method as mentioned in section 3.4. Lane 1, 
tlowthrough; lanes 2-4, wash; lanes 5-8, fractions eluted by elution buffer 1; lanes 9-13, fraction 
eluted by elution buffer 2. 
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Figure 3.7 Purification of refolded Rad21 (451-63laa). (a) Fractions purified by Ni-NTA 
column under denaturing condition. Lane 1, flowthrough; lanes 2-3, wash; lane 4, fraction eluted 
by elution buffer 1; lanes 5-11, fraction eluted by elution buffer 2. (b) Fractions from the gel 
filtration column. Lane 1, samples before refolding; lane 2, samples after refolding and before 
being loaded onto the gel filtration column; lanes 3-13, fractions eluted from the gel filtration 
column. (c) The gel filtration chromatogram for Rad21 (451-63laa). 
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column were analyzed by a 12% SDS-PAGE gel and subsequently stained by Coomassie 
blue. All the fractions analyzed contained the upper band except for lane 13 (Figure 3.7b). 
Three 'peaks' could be assigned to the gel filtration chromatogram based upon the 
protein concentration in different fractions on the Coomassie stained gel (Figure 3.7b 
lanes 4, 8, and 12). The three peaks were indicated by arrows 1, 2, and 3 in Figure 3.7c. 
The first peak contained only aggregates. The MW indicated by the second peak was 
approximately 150kD, suggesting that it contained both cross linked Rad21 (451-631aa) 
trimer and other Rad21 (451-63laa) oligomers. There was only one fraction that 
contained the lower band and not the upper band (Figure 3.7b, Lane13; Figure 3.7c, 
arrow 4 ). However, the amount obtained was too small for crystallization studies. 
To purify the 6 x His tagged Rad21 (280-450aa), a similar approach as described 
above was used. Rad21 (280-450aa) was overexpressed in 1 L of E. coli and eluted at pH 
4.5 from the Ni-NT A resin. To refold the protein, the purified fractions were diluted 
twenty times in a refolding buffer containing 0.4M arginine. The protein sample was 
added to the dilution buffer in a drop wise manner with constant mixing. The mixture was 
then dialyzed against a fresh dialysis buffer (50mM Tris-HCl, 20% Glycerol, 500mM 
NaCl, and lmM EDTA) for 3 x 6h. Similar to Rad21 (451-63laa), precipitates were 
observed during the refolding process and part of the refolded protein also formed a 
trimer that was difficult to dissociate (Figure 3.8b). A refolding buffer containing 0.4M 
arginine and an additional 2mM GSH/0.4mM GSSG was also tested using the same 
procedure as described above. The addition of GSH/GSSG significantly increased the 
recovery rate of the protein sample (Figure 3.9b), but the refolded product still contained 
the cross linked trimer. Upon analysis ofthe eluted samples, it was found that most of the 
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Figure 3.8 Purification of Rad21 (280-450aa) from E. coli. (a) Fractions purified by Ni-NTA 
resin under denaturing condition. Lane 1, flowthrough; lanes 2-3, wash; lane 4, fraction eluted by 
elution buffer 1; lanes 5-11, fraction eluted by elution buffer 2. (b) Fractions from the gel 
filtration column using refolded proteins. Lanes 1-3, fractions collected from the aggregation 
peak; lanes 4-11, fractions collected from the non-aggregation peak. 
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proteins were eluted with an apparent MW of -ISOkD. The proteins in these fractions 
were either cross linked trimers or oligomers of Rad2l (280-450aa). There was a small 
amount ofRad21 (280-450aa) protein, as indicated by the right arrow in Figure 3.9c, that 
was not associated with cross-linked oligomers. However, a trace amount of the cross 
linked trimer was still present in these fractions. 
The fractions from the third peak (i.e., the peak indicated by the right arrow in 
Figure 3.9c) could be collected and purified by the gel filtration column a second time, 
which may result in a more pure protein sample without the contamination of the cross 
linked trimer. However, a second round of purification by a gel filtration column is likely 
to cause the loss of some of the protein sample, resulting in a smaller amount of protein 
in the final sample. Because the Rad21 (280-450aa) protein was purified from E. coli, 
which is cheap and easy to grow, a larger scale expression and purification can be used to 
obtain sufficient Rad21 (280-450aa) for crystallization studies. 
The purification of Rad21 (280-450aa) has brought us hope to obtain sufficient 
amount of Rad21 mutant protein for crystallization studies. Because the purification of 
Rad21 (280-450aa) requires the protein to be refolded from denaturing condition, it needs 
to be tested prior to crystallization screening for correct folding. There is no immediate 
biophysical assay available to test the correct folding ofRad2l thus far. However, we can 
indirectly determine whether it is correctly folded by testing one of its biological 
functions. We have confirmed that Rad21 (280-450aa) can co-purity with SA2 (1-IOSlaa) 
in chapter IV. Therefore, correctly folded Rad21 (280-450aa) should be able to form 
complex with SA2 (1-lOSlaa) in vitro. Section 2.3 has shown that SA2 (1-lOSlaa) can be 
purified in large amount at high purity. To confirm the correct folding of Rad21 (280-
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Figure 3.9 Purification of Rad21 (280-450) denatured and refolded using GSH/GSSG. (a) 
Ni-NT A purification of Rad21 (280-450aa) under denaturing condition. Lane 1, supernatant; lane 
2, pellets dissolved in 8M urea; lane 3, flowthrough from Ni-NTA resin; lane 4, wash; lane 5, 
fraction eluted by elution buffer 1; lanes 6-11 , fractions eluted by elution buffer 2. (b) (c) Gel 
fi ltration chromatogram (c) and eluted fractions on SDS-PAGE (b). Lane 1, fraction from the 
aggregation peak (indicated by the left arrow); lanes 2-8, fractions from the second peak (middle 
arrow); lanes 9-1 3, fractions from the third peak (right arrow). 
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450aa), the purified Rad21 (280-450aa) protein will be mixed with purified SA2 (1-
1051aa) and the mixture samples will be analyzed by gel filtration column. The eluted 
peak will be used to compare with the peak of SA2 (1-lOSlaa) alone to determine 
whether they form a complex or not. Because the molar ratio of the Rad21 (280-450aa): 
SA2 (l-105laa) complex is unknown, different molar ratios (1:1, 1:2, 2:1) will be tested 
in the gel filtration purification. 
3.5 Future direction of structural studies of Radll 
The Rad21 deletion mutants were difficult to purifY and readily formed 
aggregates, suggesting disordered structures of the Rad21 protein. A secondary structure 
prediction was performed using PredictProtein (Rost et al., 2004) for the human Rad21 
(Figure 3.10). The secondary structure prediction showed that the middle region ofRad21 
(171-450aa) was largely unstructured I disordered. The region only contained three a-
helices, one of which was predicted with very low probability. Therefore, it might be 
very difficult to crystallize the protein. However, section 3.4 has shown that it is possible 
to obtain sufficient amount of Rad21 (280-450aa), which is part of the middle region of 
Rad21. To confirm its predicted secondary structure, purified Rad21 (280-450aa) can be 
used for CD measurement and secondary structure calculation. The results obtained from 
CD will be compared to the predicted secondary structure. In addition, nuclear magnetic 
resonance (NMR) spectroscopy is a feasible way to analyze the structure of the protein 
due to its small size. Another way to study the structure of the Rad21 middle region is to 
study the structure of a complex formed by the Rad21 middle region and another Rad21 
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binding protein. The formation of the complex may decrease the flexibility of the Rad2l 
molecule and facilitate the formation of crystals. 
The secondary structure prediction also showed that, compared to the middle 
region of Rad2l, the N-terminus (l-170aa) and C-terminus (451-631aa) were more 
structured, containing more a-helices and ~-strands with higher probability, which made 
them better targets for crystallization (Figure 3.1 0). The Rad21 protein is conserved from 
yeast to human, sequence alignment showed -33% similarity between the yeast and the 
human Rad21 proteins (Figure 3.11). TheN-terminus (1-170aa) shares -40% similarity 
with the yeast Rad21, while the middle region and the C-terminus shares -30% similarity. 
A secondary structure prediction for the yeast Rad21 also showed a largely unstructured 
middle region of the yeast Rad21 (Figure 3.12) and structured N- and C- termini. 
Therefore, the crystallization studies of the human Rad21 protein will focus on the N-
and the C- termini in the future. 
The whole human Rad21 N-terminus has been shown difficult to express in 
section 3.1. By examining the secondary structure prediction result, the helices and 
strands all located within the first 90aa (Figure 3.10). In yeast, theN-terminal 1-115aa 
has been shown to be sufficient binding to Smc3 (Gruber eta/., 2003). The human 1-
100aa is conserved to the yeast 1-115aa (Figure 3.11), suggesting it might be a structured 
functional region on its own. This region also excluded the largely unstructured 101-
170aa region, which may pose a problem for protein expression and purification. 
Therefore, the human Rad2l 1-l OOaa can be used as a target for crystallization. 
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Figure 3.10 Secondary structure prediction for the human Rad21. Rad21 amino acid 
sequence is colored based on residue types (e.g. blue for positively charged, red for negatively 
charged, green for hydrophobic, silver for polar, etc). PROF _sec predicts the secondary structure 
(H = Helix, E = strand). Rel_Sec shows the reliability index of the PROF _sec prediction (O=low, 
9=high). 
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Figure 3.11 Alignment of the human and yeast Rad21. The sequence alignment was prepared 
using BioEdit (Hall, 1999). 
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Figure 3.12 Secondary structure prediction for the yeast Rad21. Rad21 amino acid sequence 
is colored based on residue types (e.g. blue for positively charged, red for negatively charged, 
green for hydrophobic, silver for polar, etc). PROF _sec predicts the secondary structure (H = 
Helix, E = strand). Rei_ Sec shows the reliability index of the PROF _sec prediction (O=Iow, 
9=high). 
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In addition to the N-terminus, crystallization targets can also be designed 
according to the C-terminal structural information. The structure of the yeast C-terminal 
(451-566aa) has been solved as mainly forming winged helix domains. The 512-631aa 
from the human Rad21 is conserved to this part and it contains multiple a-helices and P-
strands with high probability. The human (451-631aa) has been shown hard to purity, 
which might be due to the unstructured 451-511aa region. The shorter 512-631aa might 
be a better crystallization target. 
To study the structure ofhuman Rad21, Rad21 (1-lOOaa) and Rad21 (512-631aa) 
will be cloned and expressed in E. coli. If the proteins are hard to express or purity, insect 
cell system will be used as an alternative. The yeast Rad21 C-terminal 451-566aa, whose 
structure was solved, was expressed in insect cell system instead of yeast system 
(Haering eta/., 2004), which might indicate that the Rad21 protein is very difficult to 
express and purity. The human Rad21 might adopt a more complex folding pathway and 
more elaborated modifications compared to its yeast homolog. Therefore, a more delicate 
expression system might be required to prepare the human Rad21 protein. 
In addition to the crystallization method, NMR spectroscopy can be an alternative 
method to determine the structure of the Rad21 mutants due to their small size. 
If it is still hard to solve the structure of human Rad21, the Rad21 protein from 
other mammals can be tested. Rad21 is a highly conserved protein among mammals. 
Small differences in sequence can have dramatic crystallization of a protein. Rad21 
proteins from other mammals, such as mice, can be tested to determine if they are good 
crystallization targets. 
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Chapter IV. Biochemical and biophysical characterization of the 
SA2:Rad21 complex 
It has been previously reported that in yeast, Scc3 (known as SAl/2 in human) 
associates with the cohesin ring via interacting with Sccl (known as Rad21 in human; 
Haering eta/., 2002). However, it is unclear whether the physical association of human 
SA2 and Rad21 takes place through direct binding and/or if this association requires 
additional cohesin associated components for their association in the cohesin ring to take 
place. Furthermore, a detailed map of the Rad21-SA2 interaction domains and the 
functional mechanism of SA2 in sister chromatid cohesion have not been described. The 
studies on the interaction between the human Rad21 and SA2 are reported in this chapter. 
4.1 The interaction between Rad21 and the SA2 deletion mutants 
To study the interaction between Rad21 and SA2, the interacting regions of both 
proteins need to be mapped. A co-purification method combined with mutagenesis was 
used to map the regions of SA2 that can interact with the full length Rad21. The mapping 
started by examining two SA2 deletion mutants, SA2 (1-1051aa) and SA2 (1052-1231aa), 
the sequences of which do not overlap with each other. Among them, SA2 (1-1051aa) 
was identified in section 2.3 as a stable SA2 deletion mutant that did not degrade during 
the purification process. 
To examine the interaction between the Flag tagged Rad21 and the two 6 x His 
tagged SA2 deletion mutants, -2 x 107 sf21 cells were infected with baculovirus 
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overexpressing Rad21 along with baculoviruses overexpressing either SA2 (1-IOSlaa) or 
SA2 (1052-123laa) at an MOl of 4:2 respectively. Cells were collected 48h post-
infection by centrifugation at I ,OOOg for 6min. The cell pellets were washed with PBS 
and resuspended in 2ml of lysis buffer. The resuspended cells were incubated on ice for 
30min, with occasional vortexing. After incubation, the supernatants were collected by an 
18,000g x IS min centrifugation. The supernatants were split into two halves. I ml of 
supernatants from each sample was added to 20J.d of Ni-NT A agarose beads 
supplemented with SM NaCl and IM imidazole, to achieve a final concentration of 
300mM NaCl and 20mM imidazole. Another I ml of supernatant from each sample was 
added to 20ul Flag monoclonal antibody (mAb) conjugated agarose beads (Flag beads; 
Sigma-Aldrich) supplemented with SM NaCl, to achieve a final concentration of ISOmM 
NaCI. 
For Ni-NT A co-purification, the samples were rotated at 4°C for lh and washed 
three times with 340ul ofNi-NT A buffer A and the tagged proteins were then eluted with 
2 x SDS sample buffer (125mM Tris-HCl, pH=6.8, 20% glycerol, 4% SDS, 0.1% 
bromophenol blue, IOOmM OTT}. For Flag beads co-purification, the samples were 
gently rotated at 4°C for 3h, followed by three Smin washes with 340ul PBS. The tagged 
protein was eluted by 2 x SDS sample buffer. The obtained co-purification samples, 
together with the supernatants, were analyzed by western blot using either an anti-Flag 
polyclonal antibody (pAb; Sigma-Aldrich) or an anti-6 x His mAb respectively. The 
influenza A virus PA protein with a 6 x His tag at the N-terminus was used as a negative 
control because the PA protein is a non-sticky monomer which does not bind to the 
Rad21 (Guu et a/., 2008). To run the western blot, cell lysates and co-purification 
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samples were loaded onto a 5% - 20% gradient SDS-PAGE gel, and electrophoresed at 
l75V for about SOmin. The samples were then transferred to a nitrocellulose membrane 
(Bio-Rad) at II OV for 60min. The membranes were blotted with blocking buffer (LI-
COR Biosciences, Lincoln, NE) for I h before being probed with the appropriate primary 
antibodies for Ih, followed by three washes in TBST buffer (pH=7.4, 20mM Tris-HCI, 
150m NaCl, 0.1% Tween 20). The membranes were then probed with appropriate 
secondary antibodies labeled with IRDye 800 or Cy 5.5 for Ih, followed by three washes 
in TBST buffer. The membranes were then visualized by an Odyssey Infrared Scanner 
(LI-COR Biosciences). 
The reciprocal Ni-NTA and Flag co-purification results showed that SA2 (I-
IOSiaa) but not the C-terminal SA2 (1052-I23Iaa) could co-purify with Rad2I (Figure 
4.I). The results suggested that the N-terminal IOSiaa are sufficient and that the C-
terminal I80aa are not required for the Rad2I-SA2 interaction. 
To further narrow down the region of SA2 responsible for the Rad2I-SA2 
interaction, the other SA2 deletion mutants obtained in section 2.5 were tested in the co-
purification experiment with Rad2I. Rad2I was expressed with each of the SA2 deletion 
mutants (Figure 2.lla) in Sf2I cells and the co-purification procedures using both Ni-
NT A and Flag beads were carried out as described above. The co-purified samples were 
analyzed by western blot. Results showed that amino acids I-302aa and 75I-I05Iaa are 
not critical for the SA2-Rad2I interaction (Figure 4.2). It was noticed that, SA2 (I-903aa) 
showed a weak interaction, while SA2 (I-750aa) and SA2 (I-IOSiaa) both showed a 
strong interaction with Rad2I (Figure 4.2). The weak interaction ofSA2 (1-903aa) might 
be a result of a disturbed structure/protein misfolding. Indeed, GlobPlot (Linding et al., 
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Figure 4.1 Rad21 interacts with SA2 (1-1051aa). Flag tagged Rad21 was co-expressed in Sf21 
cells with 6 x His tagged either SA2 (1-105laa) or SA2 (1052-123laa) and co-purified using Ni-
NT A or Flag beads. Rad21 co-expressed with the influenza A virus P A protein was used as a 
negative control. Western blot analysis was carried out using either the FLAG polyclonal 
antibody (pAb) or the 6xHis monoclonal antibody (mAb). Nonspecific bands are marked by 
asterisks. 
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Figure 4.2 Characterization of the interaction between Rad21 and the SA2 mutants. Flag-
tagged Rad21 WT was co-expressed with His-tagged SA2 deletion mutants and co-
purified by Ni-NT A or Flag beads. The influenza A virus PA was used as a negative 
control. Nonspecific bands are marked by asterisks. 
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2003) also predicted that SA2 (850-940aa) might form a globular domain, consistent with 
our hypothesis. Interestingly, 1-450aa and 587-1051aa, two regions without any 
overlapping sequences, both interacted with Rad21 (Figure 4.2, lanes 17 & 31 and 24 & 
38), indicating that SA2 interacts with Rad21 via multiple peptide stretches and that the 
structural integrity of the whole SA2 protein, or at least the region containing amino acids 
303-750, may be important for the Rad21-SA2 interaction. 
4.2 The interaction between SAl and the Radll deletion mutants 
Previous studies have shown that the yeast Rad21 is cleaved by Separase at R 180 
and R268 (Uhlmann et a/., 1999) and the yeast SA2 binds to the Rad21 C-terminal 
Separase cleavage product (269-566aa) (Haering et al., 2002; Gruber et al., 2003). How 
human SA2 binds to Rad21 remains unknown. Human Rad21 is cleaved by separase at 
R172 and R450 (Hauf eta/., 2001). To determine the region of human Rad21 that interacts 
with SA2, the Rad21 deletion mutants described in section 3.1 were tested (Figure 3.1). 
SA2 (1-1051aa), with a 6 x His tag at theN-terminus, was expressed along with 
the full length Rad21 and each of its deletion mutants, all Flag-tagged at their N-terminus. 
Co-purification was then performed as described previously using Ni-NT A and Flag 
beads to examine the interaction between SA2 and the Rad21 deletion mutants. Sf21 cells 
infected with SA2 (1-1051aa) and the Flag tagged influenza PA protein were used as a 
negative control. The results showed that SA2 (1-1051aa) can form a complex with 
Rad21 (171-450aa) but not with Rad21 (1-172aa) or Rad21 (451-631aa). This indicates 
that unlike in yeast, where the C-terminal Separase-cleaved fragment was responsible for 
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interacting with Scc3, in humans only the middle Separase cleavage fragment of Rad21 
binds to SA2 (Figure 4.3). SA2 (1-1051aa) seemed to be able to pull down a small 
amount of Rad21 ( 451-631 aa) (Figure 4.3), which was likely due to a non-specific 
interaction and the high expression level of Rad21 ( 451-631 aa). 
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Figure 4.3 Rad2l interacts with SA2 through its middle region (383-392aa). Rad21 interacts 
with SA2 through the middle region (171-450aa). His-SA2 (l-105laa) was expressed along with 
Flag-Rad21 WT and deletion mutants and the complex was co-purified with Ni-NTA or Flag 
beads. SA2 ( 1-1051 aa) co-expressed with Flag tagged P A protein was used as a negative control. 
To further narrow down the polypeptide region of Rad21 that interacts with SA2, 
we generated baculoviruses overexpressing progressive Rad21 deletion mutants with ~35 
amino acid increments/decrements from either the N- or C-terminus of the Rad21 middle 
region (171-450aa) (Figure 4.4a). SA2 (1-1051aa) along with each ofthe Rad21 deletion 
mutants were expressed in Sf21 cells. The complex was then purified using either Ni-
NT A or Flag beads and analyzed by western blot. Sf21 cells infected with SA2 (1-1 051 aa) 
and Flag tagged PA was used as a negative control. As shown in Figure 4.4b, Rad21 
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Figure 4.4 Rad21 (171-382aa) does not interact with SA2. (a) Schematic illustration of the 
middle portion Rad21 deletion constructs made in the baculovirus system. (b) His-SA2 (1-
1051 aa) was expressed along with the Flag tagged Rad21 deletion mutants, and the complex was 
co-purified with Ni-NTA or Flag beads. Contaminating antibody bands are marked by asterisks. 
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(3SI-450aa), but not Rad2I (I7I-382aa), forms a complex with SA2 (I-IOSiaa) (Figure 
4.4b, lanes I8 and 28 vs. lanes 12 and 22). Another mutant of interest, Rad2I (383-
450aa), was also co-purified with SA2 (I-IOSiaa) using Flag-beads (Figure 4.4b, lane 
I9), but the efficiency ofSA2 to co-purify Rad2I (383-450aa) using Ni-NTA beads was 
low (Figure 4.4b, lane 29), likely due to the low expression level of Flag-Rad2I (383-
450aa) (Figure 4.4b, lane 9). These results indicated that 3SI-450aa ofRad2I is sufficient 
for its interaction with SA2, and that Rad21 (383-450aa) is the minimal interacting region 
to form a SA2-Rad2I complex in vitro. 
4.3 Purification and crystallization of the SA1/l:Rad21 complex 
To further investigate ifthe human SA2 binds directly to Rad2I and to verify the 
interacting domains we have identified in SA2 and Rad2I, we co-expressed SA2 (I-
IOSlaa) and Rad2I (I7I-450aa) and purified the complex from Sf21 cells, in which no 
other human proteins were present. Approximately I x I 09 Sf2I cells were co-infected 
with baculoviruses overexpressing 6xHis tagged SA2 (I-lOSiaa) and Flag tagged Rad21 
(I7I-450aa) at an MOl of2:4. Sf2I cells were harvested 60h post-infection. Cell pellets 
were suspended in 60ml of Ni-NT A buffer A. The cell pellets were lysed by sonication 
and then centrifuged at 35,000g for 40min. The supernatant was then collected and 
loaded onto 2ml ofNi-NT A resin which was pre-equilibrated with Ni-NT A buffer A. The 
mixture was gently stirred at 4°C for one hour and then centrifuged at l,OOOg for 3min to 
separate the beads from the flow through. The resin was washed by 2Sml of Ni-NT A 
buffer A. After the wash, the complex was eluted by Ni-NT A buffer B. The eluted 
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protein solution containing the complex was diluted three times by FPLC buffer A before 
being loaded onto a 5ml Hitrap Q column. Samples were eluted using an increasing 
gradient of salt at pH 7.5. The complex was eluted at 400mM NaCl. Fractions containing 
the complex were collected, concentrated, and loaded onto a 24ml Superose6 gel 
filtration column. A gel filtration buffer (25mM Tris-HCl pH=7.5, 200mM NaCl, and 5% 
glycerol) was used to elute the protein. The complex was eluted as a single peak in the 
gel filtration chromatogram at a position earlier than SA2 (l-105laa) alone (Figure 4.5). 
The sample was more than 90% pure. To determine the ratio of the two proteins, the 
sample was analyzed by Coomassie blue G-250 stained SDS-PAGE. The intensity of the 
bands representing each of the protein was quantified using ImageJ (Rasband, 
rsbweb.nih.gov/ij/, 1997-2008) and then normalized by the number of amino acids of 
each protein. The estimated molar ratio of SA2 (1-105laa) and Rad21 (171-450aa) was 
1:1. 
The SA2 (l-105laa) ortholog, SAl (l-1055aa) was also co-purified with Rad21 
(171-450aa) using the same procedure as described above. Similarly, the SAl (l-
1055aa):Rad21 (171-450aa) complex was eluted as a single peak from a gel filtration 
column earlier than SAl (l-1055aa) alone (Figure 4.6). The molar ratio of the two 
proteins was also estimated to be 1:1. Approximately lmg SAl (1-1055aa): Rad21 (171-
450aa) could be purified from lL insect cells at the purity of>90%, which was sufficient 
for crystallization screenings. Unfortunately, the complex precipitated in more than 80% 
of the conditions using the Classic Lite kit (Hampton research) even at 2mg/ml. It also 
precipitated heavily in multiple other screening conditions. 
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Figure 4.5 SA2 (1-105laa) and Rad21 (171-450aa) form a stable complex. Gel filtration 
chromatogram for the SA2 (1-1 051 aa): Rad21 (171-450aa) complex. Inset shows the Coomassie-
stained gel ofthe SA2:Rad21 complex purified by gel filtration. 
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Figure 4.6 SAl (1-1055aa) and Rad21 (171-450aa) form a stable complex. Gel filtration 
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Estimating the ratio of SA2 and Rad21 in the complex from a Coomassie stained 
gel is a rough method, more accurate approaches are required to determine the 
stoichiometry of complex. We employed different methods, including directly visualizing 
the complex with TEM, using AU to determine the MW, and purifying the complex 
containing two differently tagged Rad21. 
4.4 EM studies of the SAl:Radll complex 
Purified SA2 (1-1051aa): Rad21 (171-450aa) was visualized by a transmission 
electron microscope (TEM). Negative staining method was used to prepare the samples 
for TEM. The purpose of negative staining is to embed protein molecules in heavy atom 
stains (e.g., uranium, tungsten, etc.) in order to enhance the contrast between the sample 
and the background for observation. To prepare a protein sample by negative staining, a 
negative staining solution (0.75% uranyl formate (Polysciences, Inc.), with the addition 
of SM NaOH to reach a dark yellow appearance) was freshly made and filtered with a 
0.22 ~m filter (Millipore ). Copper grids coated with carbon (Polysciences, Inc.) were 
placed in a vacuum chamber and glow discharged at SmA for 1 min to increase the 
hydrophilicity of the carbon surface. 3~1 of SA2 (1-1051aa):Rad21 (171-450aa) at a 
concentration of approximately 0.05mglml was loaded onto the discharged copper grid. 
Excess sample was removed after lmin with filter paper by drawing round the edge of 
the copper grid. The grid was then washed twice with MQ water, once with a drop of 
staining solution, and stained in a second drop of staining solution for 45s. Excess 
staining solution was removed with filter paper and the grid was air-dried before use. 
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A Joel 2010 TEM was used to image the samples. Micrograph of the SA2 (1-
IOSlaa): Rad21 (171-450) complex sample was captured at a magnification ofSOOOO X 
(Figure 4.7a). The magnified view of the particles (Figure 4.7b) revealed that the 
complex contained multiple domains. The number of domains seemed to vary slightly 
between the particles, which might be a result of the difference in orientation. Since 
Rad21 (171-450aa) is a small protein which is predicted to be largely unstructured, it 
might only occupy one of the domains as shown in the micrograph. The SA2 (1-IOSlaa) 
protein contains roughly three more times of amino acids than Rad21 (171-450aa}, 
therefore, it might occupy the rest of the domains. Even there are two molecules of 
Rad21 (171-450aa) in each complex, SA2 (1-1051aa) is still likely to contain 5-6 
domains (Figure 4.7b). To assign the domains to each protein, we can add an anti-6 x His 
mAb to the complex sample. The 6xHis antibody targets the N-terminal of SA2 (1-
1051aa), while SA2 (303-750aa) was found to be interacting with Rad21, therefore the 
addition ofthe antibody should not interfere with the interaction between SA2 and Rad21. 
We were not able to determine the stoichiometry of the complex from the EM 
micrograph. It is likely that negative staining method could cause the collapse of the 
complex structure in the sample preparation. This issue can be addressed using cryo-EM 
as an alternative method. 
4.5 Stoichiometry studies of the SA112:Rad21 complex 
We have shown that Rad21 and SAl/2 form a stable complex. However, the 
stoichiometry of the proteins in the complex remains unknown. The one ring model 
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Figure 4.7 TEM picture of the purified SA2 (1-1051aa):Rad21 (171-450aa) complex. (a) A 
general view ofthe SA2 (1-105laa): Rad21 (171-450aa). Scale bar: 50nm. (b) Magnified view of 
the general shape of the complex. Scale bar: 1 Onm. 
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suggests that each cohesin complex contains one molecular copy for each of the four 
cohesin core subunits. Therefore, SAI/2 and Rad21 should form a complex at the 1:1 
ratio. The handcuff model proposes that two Rad21 molecules interact with each other in 
presence of SAl/2 (Zhang eta/., 2008), suggesting that SAl/2 and Rad21 may form a 
complex at the 1 :2 ratio. To differentiate between these two models, I used analytical 
ultracentrifugation to determine the molecular stoichiometry of the SAl/2: Rad21 
complex by measuring the MW of the complex. 
SV experiments were performed on both SA2 (1-lOSlaa) and the SA2 (1-
1051aa):Rad21 (171-450aa) complex using a Beckman Coulter Optima XL-A analytical 
ultracentrifuge. The OD values of the samples were obtained against a water reference at 
230nm. The sedimentation velocity experiments were performed at 30,000rpm (AN60 
Rotor) and 4°C for ISh. One hundred and fifty scans were recorded for each sample at a 
radial step size of 30J.Lm. Data analysis was performed as described in Section 2.8. The 
G(s) ofSA2 and the SA2 (1-lOSlaa): Rad21 (171-450aa) complex are shown in Figure 
4.8. The SA2 (1-105laa):Rad21 (171-450aa) complex showed larger value of 
sedimentation coefficient as compared to SA2 (1-lOSlaa) alone, indicating that SA2 (1-
IOSlaa) and Rad21 (171-450aa) indeed form a stable complex. 
To determine the MW of the SA2 (1-1051aa):Rad21 (171-450aa) complex, the 
same approach was used as described above. The G(s) of the complex at the two different 
concentrations are shown in Figure 4.9a, suggesting no oligomerization during data 
collection. The global Monte-Carlo analysis showed that there was one major species 
with the molecular weight of 151.8 (144.2, 168.1) and a frictional ratio of 1.82 (1.72, 
2.22) (in parenthesis: 95% confidence intervals). This species should be the complex. If 
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SA2 and Rad2I form a complex at I :I ratio, the theoretical MW is I54.6. If the complex 
is formed at I:2 ratio, the theoretical MW is I87.4. Based on the calculated MW, Rad21 
and SA2 should form a I: I complex. However, if the complex contained a trace amount 
of I :2 complex, the AU method might not be accurate enough to detect it. To address this 
question, 6 x His tagged Rad2I and Flag tagged Rad2I were co-expressed with HA 
tagged SA2 and purified in the order ofNi-NT A column, anion exchange column and gel 
filtration column. If SA2 and Rad2I do form a I :2 complex, Flag tagged Rad2I will be 
detected in the fractions collected from the major peak of the gel filtration. The fractions 
from the gel filtration column were analyzed by anti Flag mAb. We did observe a small 
amount of Flag tagged Rad21 (17I-450aa) in the fractions from the major peak (Figure 
4.IOa, lanes 3-6) but the amount ofthe Flag tagged Rad2I (I7I-450aa) in the aggregation 
peak (Figure 4.I Oa, lane I) was much more significant consistent with the observation in 
section 3.3 that Rad2I (I7I-450aa) had a strong tendency to form aggregates. The small 
amount ofFlag tagged Rad21 (17I-450aa) found in fractions around the major peak may 
reflect the existence of a small amount of the I :2 SA2: Rad2I complex. It was suggested 
that in vivo the population of the dimerized cohesin rings is much smaller comparing to 
the population of the single cohesin ring (Zhang eta/., 2008). On the other hand, it is also 
possible that the small amount of Flag tagged Rad2I (I7I-450aa) detected in the major 
peak might be due to leaking of aggregated Rad21 (171-450aa) from the aggregation 
peak (Figure 4.1 Ob ). 
We have also performed sedimentation velocity experiment for the SAl (I-
I055aa):Rad21 (17I-450aa) complex. The G(s) of the complex at the two different 
concentrations are shown in Figure 4.9b, suggesting no oligomerization during data 
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Figure 4.8 Velocity sedimentation results for SA2 (l-105laa) and the SA2 (1-1051aa): 
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Figure 4.10 Co-purification of the two differently tagged Rad21 with HA tagged SA2. (a) 
Fractions from the gel filtration chromatogram were analyzed using Coomassie staining (upper 
panel), anti 6 x His mAb (middle panel), and anti Flag mAb (lower panel). (b) Gel filtration 
chromatogram of the SA2:Rad21 complex. Lanes 1 from (a) are collected at the position indicated 
by the arrow and lanes 3-6 are collected at the elution peak for the SA2: Rad21 (171-450aa) 
complex. 
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collection The global Monte-Carlo analysis showed that there was one major species with 
the molecular weight of 166.2 (164.2, 168.7) kD and a frictional ratio of 1.97 (1.96, 2.00). 
IfSA1 (1-1055aa) and Rad21 (171-450aa) formed the complex at 1:1 ratio, the calculated 
MW would be 155.0 kD. For a 1:2 complex, the calculated MW would be 187.8. The 
predicted the MW was closer to 155.0kDa. Therefore, like SA2, SAl should form a 
complexwithRad21 (171-450aa)at 1:1 ratio. 
Our in vitro experiment showed that Rad21 and SA2 form a 1:1 complex instead 
of 2: 1 as suggested by the handcuff model. There are a few explanations for this 
contradiction. First of all, it is possible that the dimerization of Rad21 requires other 
human proteins in addition to SA2. The two molecules ofRad21 may not directly interact, 
but SA2 might help to recruit other cohesin associated proteins to facilitate the 
dimerization of Rad21. Those associated proteins would be missing in the insect cell 
system. Therefore, SA2 and Rad21 only form a complex at 1 :1 ratio when co-expressed 
in Sf21 cells. The second possibility is that the integrity of the Rad21 structure is 
necessary for the formation of a 2:1 complex. Due to the low expression level of the full 
length Rad21, only the Rad21 (171-450aa) was tested for the complex formation. 
Although the N- and C-terminus of Rad21 do not directly interact with SA2, they might 
still play a part in the dimerization. Because it is not known if SA2 is the only protein that 
directly triggers the dimerization of Rad21, it is possible that the dimerization requires 
SA2 to recruit other proteins, which triggers the dimerization through associating with 
Rad21 through the N- or C- terminus of Rad21. Without N- or C-terminus, the 
association is not able to occur and thus, there is no dimerization. The handcuff model 
suggested that the two Rad21 molecules interact with each other in an anti-parallel 
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manner (Zhang et al., 2008). Therefore, it is also possible that the interaction between 
Rad21 N- and C -termini contributes to part of the dimerization, without which, the 
dimerization is prohibited. 
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Chapter V. Characterization of the interaction between SA2 and Rad21 
in mammalian cells 
In the previous chapter, I have identified that SA2 (l-1051aa) is sufficient for 
interacting with Rad21 and Rad21 (383-450aa) is the minimal region identified for 
interacting with SA2. To further narrow down the region of Rad21 that interacts with 
SA2 and identify the key amino acids within the region will provide a better 
understanding ofthe Rad21-SA2 interaction. 
5.1 Define the amino acid residues of Rad21 essential for interaction with SA2 
To further narrow down the region of Rad21 that interacts with SA2, additional 
experiments were performed in a mammalian cell expression system. The baculovirus 
system used in previous chapters is a more convenient and lower costly system when it 
comes to large scale protein expression and purification. However, the experimental 
cycle from cloning the genes of interest to expressing the protein is much longer in insect 
cells compared to that in mammalian cells (a week vs. a month). It takes a few rounds of 
transfection and co-immunoprecipitation (IP) experiments to narrow down the region of 
interest and identify the key amino acids in Rad21 for interaction with SA2. Therefore, a 
mammalian cell expression system was chosen as a more efficient system for the 
experiments in this chapter. In addition, the cell line used in this chapter is the Human 
embryonic kidney (HEK) 293T cells. After the essential amino acids of Rad21 are 
identified in co-IP assays, the results will also be confirmed through IP of the endogenous 
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cohesin components. Therefore, 293T, as a human cell line, is the ideal cell line for the 
experiments to be carried out in this chapter. 
SA2 (1-105Iaa) was cloned into the pCS2 MT vector bearing a 6xMyc tag at the 
N-terminus. A series of Rad2I deletions mutants were designed based upon the results 
from section 4.2 and were cloned into the pFlag CMV2 vector (Figure 5.I a). The DNA 
used for each transfection was prepared by midi-prep from I OOml DH5a cells using the 
Qiagen Midi-kit. The minimal concentration of DNA used for transfection was 400ng/1J.l. 
SA2 (I-I05Iaa) was transfected along with each ofthe Rad2I deletion mutants into 293T 
cells. To perform the transfection, each IOcm tissue culture plate was seeded with 5 x I06 
293T cells in DMEM medium supplemented with IO% FBS. Approximately 51J.g of DNA 
was mixed with SOul 2.5M CaCh solution, 450ul MQ water and 500ul 2 x Hank's 
buffered salt solution (HBSS) before being incubated at room temperature for 20 
minutes. The mixture was then added to each plate and the cells were incubated at 37°C. 
Medium was changed I6h post transfection and the cells were harvested 40h post-
transfection. Cells transfected with SA2 (l-I05Iaa) along with the pFlag CMV2 empty 
vector (EV) was used as a negative control. 
To harvest the cells, medium was discarded and the cells were washed twice with 
PBS buffer. Imllysis buffer (50mM Tris-HCl, pH=7.4, I% Triton X-IOO, I50mM NaCl, 
I mM EDT A, Complete mini Protease Inhibitor cocktail tablet (Roche; I tablet in every 
IOmllysis buffer)) was then added to the cells. With the addition of the lysis buffer, the 
cells were detached from the bottom of the plates and transferred to I.Sml eppendorf 
tubes. The cells were pipetted up and down for 20 times to facilitate the breaking of the 
nuclear membranes, followed by on-ice incubation for I Omin. The cells were then spun 
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Figure 5.1 Rad21 interacts with SA2 through a lOaa region. (a) Schematic illustrations of 
Rad21 deletion constructs in the context of the full length Rad21 in the mammalian expression 
vector pFlagCMV2. (b) The Rad21 383-392aa region is critical for interacting with SA2. Myc-
SA2 (1-1051aa) was co-transfected along with the Flag-Rad21 deletion mutants and 
immunoprecipitated with Flag or Myc beads and probed with either the Myc polyclonal antibody 
(Myc pAb) or the FLAG mAb. Flag empty vector (EV) was used as a negative control. 
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down at 14,000g for 15min. The supernatants were collected and the concentration of 
each sample was measured using Bradford assay. Approximately 1.2mg protein from 
each transfection was added to either Flag beads or Myc mAb conjugated agarose bead 
(Myc beads; Sigma-Aldrich). To perform the Co-IP, samples were incubated with either 
Flag or Myc beads with constant mixing at 4°C for 3h. The beads were then washed three 
times with TBS buffer and the tagged proteins were eluted with 2 x SDS sample buffer. 
The Co-IP results were analyzed using western blot (Figure 5.lb). Rad21 (171-
392aa) was able to pull down SA2 (1-105laa) while Rad21 (171-382aa) and Rad21 (393-
631aa) were not (Figure 5.1b, Lanes 19 and 33 vs.lanes 18 & 32 and lanes 25 &39). This 
is consistent with the results obtained from the insect cells. The dramatic differences in 
the binding affinity ofRad21 (171-382aa) and Rad21 (171-392aa) with SA2 also lead to 
the conclusion that Rad21 383-392aa is crucial for interacting with SA2. A secondary 
structure prediction was performed for the Rad21 protein as mentioned in section 3.5. 
The structure prediction showed that the Rad21 middle region (171-450aa) was largely 
unstructured with three predicted a-helices, and one of them is predicted with very low 
probability (Figure 5.2a). Interestingly, one of the two a-helices with high probability 
was formed by 383-392aa. A deletion mutant devoid of the 10 amino acids from the full 
length Rad21 was cloned into the pFlag CMV2 vector. An alignment ofRad21 protein in 
different species have shown that in the 383-392aa region, amino acids L385, F389 and r 90 
are conserved (Figure 5.2b). Therefore, site mutations were designed according to the 
conserved amino acids and cloned into the pFlag CMV2 vector. 
SA2 (l-1051aa) was transfected into 293T cells along with each of the Rad21 
mutants and Co-IP was performed with both Flag and Myc beads as described above and 
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Figure 5.2 Rad21 383-392aa form an a-helix and amino acids L385, ~89 and J'l90 are 
conserved. (a) Rad21 amino acid sequence is colored based on residue types (e.g. blue for 
positively charged, red for negatively charged, green for hydrophobic, silver for polar, etc). 
PROF _sec predicts the secondary structure (H= Helix). Rei_ Sec shows the reliability index of the 
PROF _sec prediction (O=Iow, 9=high). (b) Sequence alignment ofRad21 from various vertebrate 
species. The sequence alignment was prepared using BioEdit (Hall, 1999). The conserved Rad21 
L385, F389 and T390 residues were used for making site-directed mutations. 
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analyzed by western blot. Cells transfected with SA2 (1-1051aa) and the Flag EV was 
used as a negative control. The western blot showed that the mutation of L 385 and F389 
significantly reduced the binding of Rad21 to SA2 (Figure 5.3, lanes 18 and 30). 
Furthermore, the simultaneous mutation of all the three amino acids, L385, F389 and 
T390 or the deletion of 383-392aa completely abrogated the Rad21-SA2 interaction. 
(Figure 5.3, Lanes 21 & 33 and 22 & 34). 
pCSlMT S ( ·105taat 
<t 
~ (¥- ~ 
Figure 5.3 L385 and ~89 are critical for Rad21 to interact with SA2. Rad21 L385, F389, 
and T390 are important for interaction with SA2. 
To confirm if the mutations identified above are able to disrupt the Rad21-SA2 
interaction, Myc-Rad21 wildtype (WT) or mutant Rad21 were cloned into the pCS2 MT 
vector and ectopically expressed in 293T cells. Immunoprecipitation of SA2 by WT or 
mutant Rad21 was analyzed by western blot. The results showed that the 
immunoprecipitation of endogenous SA2 was significantly reduced in Rad21 mutants 
(Figure 5.4a), which is in consistence with the above finding that amino acids L385, F389 
and T390 are essential for the Rad21-SA2 interaction. 
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The SA2 ortholog, SA 1, shares 70% sequence identity with SA2. A previous 
study has showed that the Rad21 (362-404aa) is responsible for interacting with SAl 
(Shintomi et a/., 2009) in vitro. The Rad21 (383-392aa) locates within the 362-404 
region. Therefore, it was interesting to examine whether the Rad21 (383-392aa) and its 
specific binding sites are also responsible for interacting with SA2. Myc tagged SA 1 
(courtsey of Dr. Debananda Pati) was transfected along with Flag tagged wildtype or 
mutant Rad21 into 293T cells and Co-IP was performed using Flag beads as described 
above. Cells transfected with Myc tagged SAl and the pFlagCMV2 EV was used as a 
negative control. Similar to SA2, mutation of L385 and F389 significantly reduced the 
binding ofRad21 to SA2 (Figure 5.4b). Furthermore, the simultaneous mutation of all the 
three amino acids, L385, F389 and T390 or the deletion of 383-392aa completely abrogated 
the Rad21-SA2 interaction (Figure 5.4b). To confirm this result with the endogenous 
SA 1, the IP products pulled down by Myc-tagged Rad21 proteins from the above 
experiments were analyzed by Western blot. As expected, the immunoprecipitation of 
SA 1 was reduced significantly in the Rad21 mutants compared to Rad21 WT control 
(Figure 5.4a). Therefore, the Rad21 (383-392aa) is not only responsible for interacting 
with SA2, but also play an essential in interacting with SA 1. 
To examine if the disruption of SA2 binding to Rad21 has any effect on Rad21 
association with the other cohesin core subunits, the immunoprecipitation of both Smc 1 
and Smc3 were also analyzed by western blot. Unlike SAl/2, both Smcl and Smc3 
remain unchanged in all Rad21 mutants comparing to the WT control (Figure 5.4a}, 
indicating that the disruption of Rad21-SA2 binding has no apparent effect on Smc l-
Smc3-Rad21 interaction. 
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Figure 5.4 The association of the Rad2l mutants and the cohesin subunits. (a) The amount of 
SA I /SA2 immunoprecipitated by the Rad21 mutants was significantly decreased while the 
amount of Smcl and Smc3 remained constant. (b) The Rad21 383-392aa region is critical for 
interacting with SAl in vitro. Myc-SAI was co-transfected along with the Flag-Rad21 deletion 
mutants and immunoprecipitated with Flag beads and probed with either the Myc polyclonal 
antibody (Myc pAb) or the FLAG mAb. Flag empty vector (EV) was used as a negative control. 
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5.2 Disruption of the Rad21-SA2 interaction leads to premature separation of sister 
chromatids 
To examine the physiological consequence of the disruption of the Rad21-SA2 
interaction, Myc-tagged WT and mutant Rad21 were expressed in 293T cells. Myc EV 
was used as a control. To examine the effect of the ectopic protein, endogenous Rad21 
was knocked down using Rad21 3'-UTR siRNA (Qiagen) 24h before transfection. 
Silencer Negative Control siRNA (Applied Biosystems) was used as a negative control. 
To enhance the efficiency of the knockdown, cells were treated with siRNA again 24h 
after transfection. Cells were harvest 72h after the second siRNA treatment. Three hours 
prior to the harvest, colcine was added to arrest the cells in metaphase by inhibiting 
microtubule polymerization through binding to tubulin. To harvest the cells, cells were 
treated with trypsin-EDT A solution (0.25% (w/v) trypsin and 0.2% (w/v) EDTA prepared 
in 1 x HBSS solution) for 5min. Trypsin digests the adhesion proteins in cell-cell and 
cell-matrix interactions, while EDT A, as a calcium chelator, which integrins needs to 
interact with other proteins for cell adhesion and also 'wipes' out the calcium in DMEM 
which functions as a trypsin inhibitor. Therefore, the cells are dettached after trypsin-
EDT A treatment. The cells were then centrifuged at 800g for 6min. The expression of 
WT and mutant Rad21 as well as endogenous Rad21 following siRNA treatment are 
shown in Figure 5.5a. 
To perform metaphase chromosome spread analysis, 10ml of pre-warmed 
hypotonic solution (0.075M KCl) was added to gently agitate the pellets, followed by 15 
min incubation at 37°C to break the membrane. 1ml of fixative (methanol: glacier acetic 
acid= 3:1) was added after incubation and cells were then centrifuged at 800g for 6 min 
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and supernatants were discarded. 4ml of fixative was added to each sample and incubated 
at room temperature for 30 min. Fixative was changed twice and 200J.1l of fixative was 
added after the final centrifugation and cells were resuspended. To create slides, 30J.1l was 
taken from each sample and dropped on angled slides from 10 inches above. The slides 
were then air-dried and stained in Giemsa solution for 10 min and then rinsed with water 
ten times. About 100 metaphase cells for each treatment were counted using a Zeiss 
AxioSkop 40 microscope (Carl Zeiss). 
The cells were divided into four categories: 1) chromatids with arm cohesion; 2) 
chromatids without arm cohesion but still linked at the centromeres; 3) chromatids 
separated but still in alignment with each other; and 4) single chromatids, randomly 
scattered (Figure S.Sb). In wildtype cells, around 10% of the cells showed cohesion 
defects. In the siRNA treated cells, approximately 50% precocious sister chromatid 
separation was noted in the Myc-EV control treated with Rad21 3 '-UTR siRNA, while 
33% of cohesion defects were observed in cells with the ectopic expression of Rad21. 
Therefore, the Rad21 depletion phenotype could be partially rescued by the 
overexpression of the WT Rad21 (Figure S.Sc). However, in the same assay, Rad21 
L385AF389A mutants had only about 5% rescue rate. Instead of rescuing, Rad21 l:l. (383-
392aa) caused more precocious sister chromatid separation than the Myc-EV, possibly 
due to a dominant negative effect of the deletion mutant. The dominant negative effect of 
Rad21 l:l. (383-392aa) was also apparent from the cells transfected by WT and Rad211:l. 
(383-392aa), which showed a rescue rate slightly lower than that of the cells treated by 
WT Rad21 only (Figure S.Sc). These results confirmed that amino acids 383-392 in 
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Figure 5.5 Disruption of Rad21 binding to SA2 results in premature separation of sister 
chromatids. (a) Expression of Myc-Rad21 WT and deletion mutants in 293T cells. 293T cells 
were treated with Rad21 3' -UTR or a control (Ctr) siRNA 24h before and after being transfected 
with Rad21 WT or mutant plasmids. The expression level of Myc-Rad21 was analyzed by 
Western blot using Rad21 polyclonal antibody (Rad21 pAb). (b-e) Rad21 mutations cause 
premature separation of sister chromatids. For metaphase chromosome spread analysis, ~ 100 
mitotic cells were counted for each treatment according to the categories shown in (b). The 
frequency of mitotic cells was calculated and plotted in (c). DM, double mutant L385AF389A; Del, 
~383-392; WT (Wild Type) + Del, WT + ~383-392. 
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Rad21 are not only required for the Rad21-SA2 interaction but also physiologically 
important for sister chromatid cohesion. 
5.3 Model on the role of the Radll-SAl interaction in cohesin ring maintenance 
Rad21 (383-392aa) has been identified to be important for maintaining the normal 
chromatid activity. However, it is not clear how the interruption of the Rad21-SA2 
interaction leads to the early separation of sister chromatids. 
According to the handcuff model, two Rad21 molecules interact with each other 
in the presence ofthe SAI/2. Therefore, the interruption ofthe Rad21-SA1/2 interaction 
may prevent the formation of the cohesin ring dimerization. We analyzed the IP products 
by Myc-tagged Rad21 from section 5.1 by western blot to determine ifRad21 molecules 
still pull down when the interaction with SA2 is disrupted. Western blot showed that the 
Myc-tagged Rad21 was able to pull down endogenous Rad21 (Figure 5.6). 
The result has raised two questions. First, according to the handcuff model, the 
Rad21 molecules interact with each other only in the presence of SA1/SA2 (Zhang eta/., 
2008). The mutant Rad21 fails to recruit SAl/2 to the cohesin complex, however, the 
interaction between two mutant Rad21 molecules were not affected. This seems to be a 
contradictory compared to previous findings. To address this, we noticed that the notion 
that Rad21 interacts with each other is based upon the observation from the cells in which 
SA 1/2 were knocked down. In our case, SA 1/2 still exist in the cells, only failing to bind 
to the SAl/2 protein. This might indicate that the dimerization ofRad21 molecules is an 
indirect process. It depends on SAl/2 to recruit other proteins. It is possible that SAl/2 
109 
are still localized to the chromatin in the loci that are close enough to the cohesin ring. 
Therefore, it can still recruit the protein responsible for the Rad21 dimerization. 
However, this protein remains unknown. 
Myc-Rad21 Myc-Rad21 
Myo-Rad210 - --- 1::1 Rad21 mAb Rad21-i-- - -= = ~ 
Actin 1-----1 
Figure 5.6 The association of Rad21 mutants and the endogenous Rad21. The amount of 
endogenous Rad21 immunoprecipitated by the Rad21 mutants remained constant. 
Second, if the cohesin rings are still associated with each other in the case of 
mutant Rad2I, how does it lead to the early separation of sister chromatids? An 
explanation is that the early separation of the sister chromatids is not due to the 
separation of the cohesin rings, but is due to the open of cohesin rings. It was mentioned 
in section 5 .I, that the Rad2I-Smcl-Smc3 complex remains intact in the case of mutant 
Rad2I. How is this related to the open ring? Though it has been shown that Smc I and 
Smc3 were associated with Rad2I in the absence of SA2 (Haering eta/., 2002), there is 
no conclusive evidence showing that they form a cohesive ring. It is also likely that they 
do not form a contiguous cohesin ring in the absence of Rad21-SA2 binding. Smc I and 
Smc3 form a hinge domain through the center region of each molecule and the head 
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region, consisting of theN- and C-terminus of each molecule, form an ATPase domain 
that interacts with theN- and C- terminus ofRad21 respectively (Anderson et al., 2002; 
Haering et al., 2002). If the hinge domain or one of the ATPase head dissociates, the 
three subunits will remain connected (Figure 6.1 ). SA2 is a core subunit identified in the 
cohesin complex. However, it is not clear what role SA2 plays in holding sister 
chromatids together. SA2 is a large, 1231aa protein. Our analytical ultracentrifugation 
data show that SA2 (l-1051aa) has a frictional ratio of 1.66, indicating SA2 is an 
elongated molecule. Although SA2 does not directly interact with Smc 1 or Smc3, we 
Smc3 Smc1 Rad21 
..-
SA2 
Unknown 
protein 
Figure 5.7 Model showing the Rad21-SA2 interaction and SA2 fortifying the cohesin ring. 
SA2 provides the tension to stabilize the tripartite ring either by itself or through another protein 
to stabilize the ring structure. Disruption of SA2 binding to Rad21 may lead to the collapse and 
early dissolution of the ring causing premature separation of sister chromatids. 
speculate that SA2 can recruit other cohesin associated protein/s to provide the inner 
tension required to stabilize the ring (Figure 5. 7). When the interaction between SA2 and 
Rad21 is interrupted by Rad21 mutations, SA2 fails to associate with the cohesin ring, 
and may be due to its inability to recruit the associated proteinls, leading to the collapse 
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of the cohesin ring. The collapse of the cohesin ring would fail to generate sister 
chromatid cohesion and result in the premature separation of sister chromatids. Since 
SA2 interacts with Rad21 at 383-392aa which is close to the C-terminus of Rad21, 
interruption of the C-terminal Rad21 and Smc 1 interaction in mutant Rad21 is also 
possible. How SA2 strengthens and stabilizes the cohesin ring is an important question 
and our present results provide a framework for future studies. 
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Chapter VI. Conclusions and Perspectives 
The cohesin complex has been a subject of intensive study since its core subunits 
were characterized more than a decade ago (Guacci et al., 1997). Active research has 
been conducted on the characterization and physiological function studies of the cohesin 
core subunits and other cohesin related components. However, little is known about the 
cohesin core protein SA1/SA2 other than its supportive role in the cohesin ring. Our 
characterization of the Rad21 and SA2 interaction has provided a deeper insight into how 
physically and physiologically SA2 interacts with the cohesin complex. Our studies 
provide a model for how SA2 structurally strengthens the cohesin ring through its 
interaction with Rad21. The conclusions of our studies and future research directions are 
discussed below. 
6.1 Summary of major findinp 
We have mapped the amino acid domains of the Rad21-SA2 interaction using an 
array of biochemical and cell biology methods. We found that SA2 physically interacts 
with Rad21 at multiple polypeptide regions while Rad21 interact with SA2 only through 
a 10 amino acid conserved region. Deletion of this 1 Oaa a-helix or mutation of specific 
amino acids within it can interfere with the interaction of Rad21 with SA2 both in vitro 
and ex vivo. Importantly, disruption of the Rad21-SA2 interaction by mutated Rad21 
proteins leads to premature sister chromatid separation, indicating the structural and 
physiological importance of this 1 Oaa long helix. We have also performed structural 
characterization for Rad21 and SA2, the results from which provided directions for 
113 
further investigation of the structural basis of protein-protein interaction in the cohesin 
complex. 
6.2 The Radll-SAl interaction in human oohesin 
It was previously reported that in yeast, SA2 associates with the tripartite cohesin 
ring through binding to Rad21 (Haering eta/., 2002). However, the human Rad21-SA2 
interaction at the molecular level and its consequence in chromosomal segregation are 
lacking. We have used biochemical, biophysical and cell biology methods to characterize 
the Rad21-SA2 interaction in human cohesin complex. 
6.2.1 Details of the Radll-SAl interaction 
We have shown that SA2 interacts with Rad21 at multiple amino acid domains. In 
particular, theN-terminal (1-450aa) and the middle portion (581-1051aa) of SA2, two 
non-overlapping polypeptide regions, are both capable of forming strong interactions 
with Rad21, indicating that SA2 interacts with Rad21 through a few peptide stretches, 
and the structural integrity of the whole protein may be important for their interaction. 
The C-terminal 180aa of SA2 (residues 1 052-1231aa) are dispensable for the Rad21-SA2 
interaction. 
While SA2 interacts with Rad21 through multiple regions, the Rad21 interaction 
with SA2 is restricted to a 1 Oaa a-helical region. In this 1 Oaa region, L385 and F389 are 
next to each other in the helix (Figure 6.1 }, suggesting that this particular side of the a-
114 
helix interacts with SA2. Considering the localized nature of these important Rad21 
residues, it is possible that the multiple regions of SA2 that are implicated in the Rad21-
SA2 interaction, although not adjacent in the sequence, may form a contiguous surface 
for interacting with Rad21. 
Figure 6.1 Helical wheel illustration of the Rad21 383-392aa. L385 and F389 are next to each 
other in the helix (Zidovetzki et al. , 2003). 
6.2.2 Stoichiometry of the Rad21-SA2 interaction 
The handcuff model suggested that two Rad2I molecules interact with each other 
in the presence of SAIISA2. Therefore, Rad2I and SA2 may form a 2:1 complex. 
However, the in vitro experiment showed that Rad2I and SA2 form a I :I complex 
instead of 2: I. We have provided a few explanations for this contradiction. First, it is 
possible that the dimerization of Rad2I does not solely depend on SA2. SA2 might play 
the role of recruiting other cohesin associated proteins to trigger the dimerization of the 
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Rad21. Those associated proteins are missing in the insect cell system. Therefore, SA2 
and Rad21 only form a complex at 1:1 ratio when co-expressed in the insect cell system. 
In addition, the integrity of the Rad21 structure is necessary for the formation of a 2:1 
complex. Due to the low expression level of the full length Rad21, only the Rad21 (171-
450aa) was test for the complex formation. Although theN- and C-terminus ofRad21 do 
not directly interact with SA2, they might still play a part in the dimerization by 
interacting with each other or providing a binding region for the protein that directly 
triggers the dimerization. 
6.2.3 Comparison of the Rad21-SA2 interaction between yeast and human 
In yeast, Scc3 binds to Sec 1 through its C-terminal Separase cleavage fragment 
(Haering et al., 2002). Hence, it is likely that Scc3 still associates with the cohesin 
complex after sister chromatid separation. Unlike in yeast, human Rad21 interacts with 
SA2 through a central 10 amino acid a-helical region which does not overlap with either 
theN- or C-terminal Separase cleavage products. However, sequence alignment between 
yeast Scc1 and human Rad21 using BLASTP (www. ncbi.nlm.nih.gov) shows human 
Rad21 (171-450aa) and the C-terminal cleavage fragment of yeast (269-566aa) have an 
overlapping region of -170aa (Figure 3.11 ), which includes the lOaa region. Therefore, 
after Rad21 is cleaved by Separase, it is likely that SA2 dissociates from the cohesin 
complex along with the Rad21 central cleavage product. 
It is not known why the yeast and human Scc3 subunits are differently associated 
with the cohesin complex after Separase cleavage. It may relate to the recycle of the 
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cohesin subunits. In both yeast and human, the N- and C-termini of Rad21 should 
dissociate from the Smc 1 and Smc3 heterodimer so that the heterodimer can be used as 
the 'building block' for the re-assembly of the cohesin complex. SA2 and Scc3 are also 
required to be released by dissociating from the Rad21 binding region to be recycled. In 
yeast, the dissociation of Scc3 from Rad21 might take place after the dissociation of the 
C-terminal ofRad21 from Smcl. While in human, the dissociation ofSA2 can take place 
immediately after the cleavage of Rad21, which may allow the free SA2 to perform other 
functions despite being a subunit of the cohesin complex. 
6.3 Characterization ofthe human SA2 protein 
6.3.1 The role SA2 plays in the cohesin model 
Earlier studies have shown that Smcl, Smc3 and Rad21 form a tripartite ring 
while SA2 binds to the ring through Rad21 and the formation of a Smcl-Smc3-Rad21 
complex does not require SA2 (Haering et al., 2002). However, it is not clear if SA2 is 
required for the maintenance of the ring. In our study, we have shown that SA2 is 
indispensable for maintaining the cohesive cohesin rings. Disruption in the Rad21-SA2 
interaction leads to precocious sister chromatid separation. We proposed a model for how 
SA2 maintains the cohesin ring. In the model, SA2 fortifies the cohesin ring through 
providing the tension for the stabilized ring structure (Figure 5.7). The disruption of the 
Rad21-SA2 interaction leads to the dissociation of SA2 from the cohesin complex and 
resulting in the collapse and opening of the cohesin ringls. This model can also be used to 
explain how cohesin complexes dissociate from the sister chromatids. In prophase, when 
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SA2 is phosphorylated by Plk1, the phosphorylation can cause the conformational change 
of the SA2 molecule, which can lead to the open of the cohesin ring/s in a few possible 
ways: 1) by elongating the SA2 molecule, the tension of which, will break the ring; 2) by 
shortening the SA2 molecule, which leads to the loss of the tension and the collapse of 
the ring; 3) by interfering with the interaction of SA2 and the unknown protein, leading to 
the collapse of the ring. After the ring is open, the cohesin complex is dissociated from 
the sister chromatids. How SA2 strengthens and stabilizes the cohesin ring is an 
important question and our present results provide a framework for future studies. 
6.3.2 The interaction of SAl with other proteins 
A recent study has showed that SA2 (162-290aa) is responsible for interacting 
with the transcription regulator CTCF (Xiao et al., 2011), consistent with our finding that 
N-terminal of SA2 (l-302aa) is not critical in the interaction with Rad21. We have 
identified that the SA2 (301-750aa) is important for interacting with Rad21 and the C-
terminus of SA2 (1052-1231aa) is dispensable for the Rad21-SA2 interaction. In 
metazoans, phosphorylation ofSA2 by Polo-like kinase 1(Plk1) at the chromosome arms 
during prophase is required for dissolution of arm cohesion (Sumara et al., 2000; Sumara 
et al., 2002; Gimenez-Abian et al., 2004). The C-terminus of SA2 contains 12 of the 14 
SA2 phosphorylation sites, including the 7 highly phosphorylated sites (Hauf et al., 
2005). Therefore, this region may be structurally flexible and exposed for the 
phosphorylation by Plkl. 
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Despite the phosphorylation sites at the C-terminus, the interaction sites with 
Rad21 in the middle and CTCF at theN-terminus (Xiao eta/., 2011), SA2 may also 
associate with other cohesin-related proteins. Previous studies showed that the yeast Scc3 
and Rad61 can directly form complexes in vitro (Rowland eta/., 2009). Therefore, it is 
possible that the human SA2 and PdsSA/B can directly interact with each other. 
However, this interaction region ofSA2 is yet to be determined. 
6.3.3 Comparison of the human SAl and SAl 
SAl, the other Scc3 ortholog in humans, shares -70% sequence identify with 
SA2. Most of the amino acid variations between SA I and SA2 are in the l-68aa and 
1075-1162aa regions. SA2 (301-75laa) shares 77% sequence identity with SAl, 
suggesting similar molecular interactions between SAl and Rad21. Our result showed 
that the Rad21 mutants incapable of interacting with SA2 were also unable to interact 
with SAl (Figure 5.4), thus confirming the above postulation. It is also in consistence 
with the finding that the Rad21 362-404aa is crucial for interacting with SAl (Shintomi 
eta/., 2009). Our finding has narrowed down the interaction region between Rad21 and 
SAl. 
We have shown that SAl and SA2 interact with Rad21 in similar manners, but it 
is unknown how they function differently in cells. It is likely that their association with 
other proteins leads to the differentiated function. The variation in their association with 
other proteins is likely a result of the sequence variation in theN- and C- termini, which 
are much less conservative than other regions. 
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6.4 Future directions 
There are goals I would like to pursue in the future for this project: structural 
studies of Rad21 and SA2 and characterization of the unknown protein participating in 
the formation of a cohesive cohesin ring. By pursuing these goals, we will have a better 
understanding of the protein-protein interaction of the human cohesin complex and their 
physiological function. 
6.4.1 Structural studies 
We have characterized that both SA2 and Rad21 contain disordered regions 
which made them difficult to crystallize. We have developed a few new schemes based 
upon our results from structural characterization and functional studies of the two 
proteins. 
We have proposed new deletion mutant candidates of Rad21 and SA2 for 
crystallization studies. In addition to the crystallization method, AU and CD methods will 
be used to provide information on the shape and secondary structure of the molecules. 
NMR will be used as an alternative method for solving the structure ofRad21 and SA2. 
In addition to the structural studies of a single protein, we have also proposed to 
study the structure of a complex. We have identified 10 amino acids in Rad21 that are 
critical for interacting with SA2. This 1 Oaa peptide can be used to form complex with an 
SA2 deletion mutant. For SA2, we have identified amino acids 301-750 are important. 
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However, we have not narrowed down this region. More constructs with progressive 50 
amino acids increment/decrement from the N- and C-terminus of the 301-750 region will 
be made using the mammalian cell system to further characterize the interaction between 
Rad21 and SA2. Once a smaller region is identified, we will use the insect cell expression 
system to express the identified region. Meanwhile, the 10 amino acid peptide of Rad21 
will be synthesized using a peptide synthesis system to obtain large amount of peptide. 
The purified SA2 region and the 1 Oaa Rad21 peptide will be mixed in vitro to form 
complex. The mixture will be purified using a gel filtration column. We should expect a 
left-shift of the peak of the complex comparing to the chromatogram of SA2 alone. 
MALDI-MS can also be used to determine if the 10aa peptide is in the complex. If it 
exists in the complex, we expect to see a peak at the MW of -1.25kD. The purified 
complex will then be used for crystallography and NMR studies. 
6.4.2 Characterization of the unknown protein involved in the cohesin structure 
maintenance 
It was mentioned in section 5.3 that SA2 might associate with Smc3 through the 
binding to an unknown protein. This unknown protein can be Pds5A/B, Wapi or another 
unidentified protein. 
To test if Pds5A/B and/or Wapi play the role of the unknown protein, 
immunoprecipitation products of Rad21 from the mitosis arrested cells ectopically 
expressing WT or mutant Rad21 will be examined. If the amount of immunoprecipitated 
Pds5 or W apl is reduced in the cells expressing mutant Rad21, it is very likely that they 
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play an important role in the maintenance of the cohesin ring. If neither Pds5AIB nor 
Wapi shows any difference in the immunoprecipitation, it might indicate that there is 
another protein involved in this process. To look for this protein, the IP products will be 
analyzed using in gel digestion and Mass Spec. The proteins detected by MS in both WT 
Rad21 and mutant Rad21 IP will be compared to each other. If there is a protein present 
in the IP product of WT Rad21 but not in that of the mutant Rad21, this is protein may be 
the unknown protein we are searching for. 
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Appendices 
Appendix I Recipes for buffers 
Hypotonic lysis buffer (lx): 50 mM Tris-HCl, pH=7.5, 50mM NaCl, 1% Triton X-100 
and 1mMPMSF 
Phosphate-buffered saline (PBS, 1x): 137mM NaCl, 2.7mM KCl, 8.1mM Na2HP04 and 
1.5mM KH2P04, pH=7.5 
Tris-buffered saline (TBS, 1x): TBS, 50mM Tris-HCl, 150mM NaCI, pH=7.5 
FPLC buffer A: 50mM Tris-HCI, pH=7.5, I mM EDT A, 2mM J3ME, and I mM NaN3 
Gel filtration buffer: 50mM Tris-HCI, 200mM NaCl, 10% Glycerol, lmM EDTA, 2mM 
!3-mE, and lmM NaN3 
Ni-NTA Buffer A: 50mM Tris-HCl, pH 7.5, 300mM NaCl, 20mM imidazole, 10% 
glycerol, and 0.1 mM PMSF 
Ni-NT A Buffer B: 50mM Tris-HCl, pH 7.5, 300mM NaCI, 250mM imidazole, I 0% 
glycerol, and 0.1 mM PMSF 
Ni-NT A wash buffer ( denaturative condition): 50mM Tris-HCl, 8M Urea, pH=6.3 
Ni-NT A elution buffer 1: 50mM Tris-HCI, 8M Urea, pH=5.9 
Ni-NT A elution buffer 2: 50mM Tris-HCI, 8M Urea, pH=4.5 
Refolding buffer: 50mM Tris-HCl, 20mM NaCI, 0.8mM KCl, pH=8.2 
Dialysis Buffer: 50mM Tris-HCI, 20% Glycerol, 500mM NaCI, and I mM EDT A 
SDS sample buffer (2x): 125mM Tris-HCI, pH=6.8, 20% glycerol, 4% SDS, 0.1% 
bromophenol blue, and 1 OOmM DTT 
TBST buffer: pH=7 .4, 20mM Tris-HCI, 150m NaCI, and 0.1% Tween 20 
Gel filtration buffer (for AU sample preparation): 25mM Tris-HCI pH=7.5, 200mM 
NaCI, and 5% glycerol 
Lysis buffer (for mammalian cells): 50mM Tris-HCI, pH=7.4, 1% Triton X-100, 150mM 
NaCI, lmM EDT A, Complete mini Protease Inhibitor tablet (Roche; 1 tablet in every 
lOmllysis buffer) 
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Appendix II Protein sequences 
A 2.1 Cohesin subunit SA2 [Homo sapiens] (GI: 112789530) 
MIAAPEIPTDFNLLQESETHFSSDTDFEDIEGKNQKQGKGKTCKKGKKGPAEKGKGGNGGGKPPSGPNRM 
NGHHQQNGVENMMLFEVVKMGKSAMQSVVDDWIESYKHDRDIALLDLINFFIQCSGCKGVVTAEMFRHMQ 
NSEIIRKMTEEFDEDSGDYPLTMAGPQWKKFKSSFCEFIGVLVRQCQYSIIYDEYMMDTVISLLTGLSDS 
QVRAFRHTSTLAAMKLMTALVNVALNLSINMDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDE 
IENMMNAIFKGVFVHRYRDAIAEIRAICIEEIGIWMKMYSDAFLNDSYLKYVGWTMHDKQGEVRLKCLTA 
LQGLYYNKELNSKLELFTSRFKDRIVSMTLDKEYDVAVQAIKLLTLVLQSSEEVLTAEDCENVYHLVYSA 
HRPVAVAAGEFLYKKLFSRRDPEEDGMMKRRGRQGPNANLVKTLVFFFLESELHEHAAYLVDSMWDCATE 
LLKDWECMNSLLLEEPLSGEEALTDRQESALIEIMLCTIRQAAECHPPVGRGTGKRVLTAKEKKTQLDDR 
TKITELFAVALPQLLAKYSVDAEKVTNLLQLPQYFDLEIYTTGRLEKHLDALLRQIRNIVEKHTDTDVLE 
ACSKTYHALCNEEFTIFNRVDISRSQLIDELADKFNRLLEDFLQEGEEPDEDDAYQVLSTLKRITAFHNA 
HDLSKWDLFACNYKLLKTGIENGDMPEQIVIHALQCTHYVILWQLAKITESSSTKEDLLRLKKQMRVFCQ 
ICQHYLTNVNTTVKEQAFTILCDILMIFSHQIMSGGRDMLEPLVYTPDSSLQSELLSFILDHVFIEQDDD 
NNSADGQQEDEASKIEALHKRRNLLAAFCKLIVYTVVEMNTAADIFKQYMKYYNDYGDIIKETMSKTRQI 
DKIQCAKTLILSLQQLFNEMIQENGYNFDRSSSTFSGIKELARRFALTFGLDQLKTREAIAMLHKDGIEF 
AFKEPNPQGESHPPLNLAFLDILSEFSSKLLRQDKRTVYVYLEKFMTFQMSLRREDVWLPLMSYRNSLLA 
GGDDDTMSVISGISSRGSTVRSKKSKPSTGKRKVVEGMQLSLTEESSSSDSMWLSREQTLHTPVMMQTPQ 
LTSTIMREPKRLRPEDSFMSVYPMQTEHHQTPLDYNRRGTSLMEDDEEPIVEDVMMSSEGRIEDLNEGMD 
FDTMDIDLPPSKNRRERTELKPDFFDPASIMDESVLGVSMF 
A2.2 Cohesin subunit Rad21 [Homo sapiens] (GI: 5453994) 
MFYAHFVLSKRGPLAKIWLAAHWDKKLTKAHVFECNLESSVESIISPKVKMALRTSGHLLLGVVRIYHRK 
AKYLLADCNEAFIKIKMAFRPGVVDLPEENREAAYNAITLPEEFHDFDQPLPDLDDIDVAQQFSLNQSRV 
EEITMREEVGNISILQENDFGDFGMDDREIMREGSAFEDDDMLVSTTTSNLLLESEQSTSNLNEKINHLE 
YEDQYKDDNFGEGNDGGILDDKLISNNDGGIFDDPPALSEAGVMLPEQPAHDDMDEDDNVSMGGPDSPDS 
VDPVEPMPTMTDQTTLVPNEEEAFALEPIDITVKETKAKRKRKLIVDSVKELDSKTIRAQLSDYSDIVTT 
LDLAPPTKKLMMWKETGGVEKLFSLPAQPLWNNRLLKLFTRCLTPLVPEDLRKRRKGGEADNLDEFLKEF 
ENPEVPREDQQQQHQQRDVIDEPIIEEPSRLQESVMEASRTNIDESAMPPPPPQGVKRKAGQIDPEPVMP 
PQQVEQMEIPPVELPPEEPPNICQLIPELELLPEKEKEKEKEKEDDEEEEDEDASGGDQDQEERRWNKRT 
QQMLHGLQRALAKTGAESISLLELCRNTNRKQAAAKFYSFLVLKKQQAIELTQEEPYSDIIATPGPRFHI 
I 
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Appendix III List of Clones 
Vector Insert N-terminal Tag 
pFastBac SA2 HA 
His 
His 
SA2 (1-302) His 
SA2 (1-450) His 
SA2 (1-587) His 
SA2 (1-750) His 
SA2 (1-903) His 
SA2 (1-1051) His 
SA2 (1-1122) His 
SA2 (151-1051) His 
SA2 (303-1051) His 
SA2 (451-1051) His 
SA2 (581-1051) His 
SA2 (751-1051) His 
SA2 (904-1051) His 
SA2 (1052-1231) His 
pET-Z8b Rad21 (451-631) His 
Rad21 (280-450) His 
pfastBac Rad21 Flag 
Rad21 (1-172) Flas 
Rad21 (1-450) Flag 
Rad21 (171-631) Flag 
Rad21 (451-631) Flag 
Rad21 (171-450) Flag 
Rad21 (171-350) Flag 
Rad21 (171-382) Flag 
Rad21 (171-417) Flag 
Rad21 (198-450) 
Rad21 (205-450) Flag 
Rad21 (240-450) Flag 
Rad21 (280-450) Flag 
Rad21 (316-450) Flag 
Rad21 (171-450) His 
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pFiagCMV2 Rad21 (171-350) Flag 
Vector Insert N-terminal Tag 
pFiagCMV2 Rad21 (171-364) Flag 
Rad21 (171-382) Flag 
Rad21 (171-392) Flag 
Rad21 (171-400) Flag 
Rad21 (171-417) Flag 
Rad21 (171-450) Flag 
Rad21 (351-450) Flag 
Rad21 (364-450) Flag 
Rad21 (393-631) Flag 
Rad21 (401-631) Flag 
Rad21 (418-631) Flag 
Rad21 (436-631) Flag 
Rad21(L385A) 
Rad21 (F389A) 
Rad21(L383A) Flag 
Rad21 (V397A) Flag 
Rad21(L385AF389A) Flag 
Rad21(L385AT390A) Flag 
Rad21{F389AT389A) 
Rad21(L38SAF389AT389A) 
Flag 
Flag 
Rad21 del {383-400) Flag 
pCS2MT SA2 (1-1051) Myc 
Rad21(L385AF389A) Myc 
Rad21(L385AT390A) Myc 
Rad21(F389AT389A) Myc 
Rad21(L385AF389AT389A) Myc 
Rad21 del (383-392) Myc 
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